# EDGAR Filing Document

**Accession Number:** 0001751788
**File Stem:** 0001751788-25-000145
**Filing Date:** 2025-7
**Character Count:** 260721
**Document Hash:** 43f84b50dd5dd84f3ceb58563786adcd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001751788-25-000145.hdr.sgml**: 20250725

**ACCESSION NUMBER**: 0001751788-25-000145

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 118

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250725

**DATE AS OF CHANGE**: 20250725

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DOW INC.
- **CENTRAL INDEX KEY:** 0001751788
- **STANDARD INDUSTRIAL CLASSIFICATION:** PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 301128146
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38646
- **FILM NUMBER:** 251148589

**BUSINESS ADDRESS:**
- **STREET 1:** 2211 H.H. DOW WAY
- **CITY:** MIDLAND
- **STATE:** MI
- **ZIP:** 48674
- **BUSINESS PHONE:** 9896361000

**MAIL ADDRESS:**
- **STREET 1:** 2211 H.H. DOW WAY
- **CITY:** MIDLAND
- **STATE:** MI
- **ZIP:** 48674

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dow Inc.
- **DATE OF NAME CHANGE:** 20190305

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dow Holdings Inc.
- **DATE OF NAME CHANGE:** 20180831
**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DOW CHEMICAL CO /DE/
- **CENTRAL INDEX KEY:** 0000029915
- **STANDARD INDUSTRIAL CLASSIFICATION:** PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 381285128
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-03433
- **FILM NUMBER:** 251148590

**BUSINESS ADDRESS:**
- **STREET 1:** 2211 H.H. DOW WAY
- **CITY:** MIDLAND
- **STATE:** MI
- **ZIP:** 48674-2030
- **BUSINESS PHONE:** 989-636-1000

**MAIL ADDRESS:**
- **STREET 1:** 2211 H.H. DOW WAY
- **CITY:** MIDLAND
- **STATE:** MI
- **ZIP:** 48674-2030

?xml version='1.0' encoding='ASCII'? dow-20250630

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q** 

☑ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended **June 30, 2025** 

or

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from __________to__________

![DOWdiamond-red-RGB_8-19.jpg](dow-20250630_g1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Commission**<br>**<u>File Number</u>** | **Exact Name of Registrant as Specified in its Charter,**<br>**<u>Principal Office Address and Telephone Number</u>** | **State of Incorporation or**<br>**<u>Organization</u>** | **I.R.S. Employer**<br>**<u>Identification No.</u>** |
| 001-38646 | **Dow Inc.** | Delaware | 30-1128146 |
|  | 2211 H.H. Dow Way, Midland, MI 48674 |  |  |
|  | (989) 636-1000 |  |  |
| 001-03433 | **The Dow Chemical Company** | Delaware | 38-1285128 |
|  | 2211 H.H. Dow Way, Midland, MI 48674 |  |  |
|  | (989) 636-1000 |  |  |

---

Securities registered pursuant to Section 12(b) of the Act:

---

| | | | |
|:---|:---|:---|:---|
| **Registrant** | **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| **Dow Inc.** | Common Stock, par value $0.01 per share | DOW | New York Stock Exchange |
| **The Dow Chemical Company** | 0.500% Notes due March 15, 2027 | DOW/27 | New York Stock Exchange |
| **The Dow Chemical Company** | 1.125% Notes due March 15, 2032 | DOW/32 | New York Stock Exchange |
| **The Dow Chemical Company** | 1.875% Notes due March 15, 2040 | DOW/40 | New York Stock Exchange |
| **The Dow Chemical Company** | 4.625% Notes due October 1, 2044 | DOW/44 | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Dow Inc.** | ☑ | Yes | ☐ | No | **The Dow Chemical Company** | ☑ | Yes | ☐ | No |

---

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Dow Inc.** | ☑ | Yes | ☐ | No | **The Dow Chemical Company** | ☑ | Yes | ☐ | No |

---

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Dow Inc.** | Large accelerated filer  | ☑ | Accelerated<br>filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | ☐ | Emerging growth company | ☐ |
| **The Dow Chemical Company** | Large accelerated filer | ☐ | Accelerated<br>filer | ☐ | Non-accelerated filer  | ☑ | Smaller reporting company | ☐ | Emerging growth company | ☐ |

---

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| **Dow Inc.**  | ☐ | **The Dow Chemical Company** | ☐ |

---

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Dow Inc.** | ☐ | Yes | ☑ | No | **The Dow Chemical Company** | ☐ | Yes | ☑ | No |

---

Dow Inc. had 708,844,151 shares of common stock, $0.01 par value, outstanding at June 30, 2025. The Dow Chemical Company had 100 shares of common stock, $0.01 par value, outstanding at June 30, 2025, all of which were held by the registrant's parent, Dow Inc.

The Dow Chemical Company meets the conditions set forth in General Instruction H(1)(a) and (b) for Form 10-Q and therefore is filing this form with the reduced disclosure format.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Dow Inc. and Subsidiaries**

**The Dow Chemical Company and Subsidiaries**

**QUARTERLY REPORT ON FORM 10-Q**

**For the quarterly period ended June 30, 2025** 

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **<u>PAGE</u>** |
| **<u>[PART I – FINANCIAL INFORMATION](#i139c2cbd4ae6490591e4e20286513220_16)</u>** | **<u>[PART I – FINANCIAL INFORMATION](#i139c2cbd4ae6490591e4e20286513220_16)</u>** | |
| <u>[Item 1.](#i139c2cbd4ae6490591e4e20286513220_19)</u> | <u>[Financial Statements](#i139c2cbd4ae6490591e4e20286513220_19)</u>. | <u>[5](#i139c2cbd4ae6490591e4e20286513220_19)</u> |
|  | **Dow Inc. and Subsidiaries:** |  |
|  | <u>[Consolidated Statements of Income](#i139c2cbd4ae6490591e4e20286513220_22)</u>. | <u>[5](#i139c2cbd4ae6490591e4e20286513220_22)</u> |
|  | <u>[Consolidated Statements of Comprehensive Income](#i139c2cbd4ae6490591e4e20286513220_25)</u>. | <u>[6](#i139c2cbd4ae6490591e4e20286513220_25)</u> |
|  | <u>[Consolidated Balance Sheets](#i139c2cbd4ae6490591e4e20286513220_28)</u>. | <u>[7](#i139c2cbd4ae6490591e4e20286513220_28)</u> |
|  | <u>[Consolidated Statements of Cash Flows](#i139c2cbd4ae6490591e4e20286513220_31)</u>. | <u>[8](#i139c2cbd4ae6490591e4e20286513220_31)</u> |
|  | <u>[Consolidated Statements of Equity](#i139c2cbd4ae6490591e4e20286513220_34)</u>. | <u>[9](#i139c2cbd4ae6490591e4e20286513220_34)</u> |
|  | **The Dow Chemical Company and Subsidiaries:** |  |
|  | <u>[Consolidated Statements of Income](#i139c2cbd4ae6490591e4e20286513220_37)</u>. | <u>[10](#i139c2cbd4ae6490591e4e20286513220_37)</u> |
|  | <u>[Consolidated Statements of Comprehensive Income](#i139c2cbd4ae6490591e4e20286513220_40)</u>. | <u>[11](#i139c2cbd4ae6490591e4e20286513220_40)</u> |
|  | <u>[Consolidated Balance Sheets](#i139c2cbd4ae6490591e4e20286513220_43)</u>. | <u>[12](#i139c2cbd4ae6490591e4e20286513220_43)</u> |
|  | <u>[Consolidated Statements of Cash Flows](#i139c2cbd4ae6490591e4e20286513220_46)</u>. | <u>[13](#i139c2cbd4ae6490591e4e20286513220_46)</u> |
|  | <u>[Consolidated Statements of Equity](#i139c2cbd4ae6490591e4e20286513220_49)</u>. | <u>[14](#i139c2cbd4ae6490591e4e20286513220_49)</u> |
|  | **Dow Inc. and Subsidiaries and The Dow Chemical Company and Subsidiaries:** |  |
|  | <u>[Notes to the Consolidated Financial Statements](#i139c2cbd4ae6490591e4e20286513220_52)</u>. | <u>[15](#i139c2cbd4ae6490591e4e20286513220_52)</u> |
| <u>[Item 2.](#i139c2cbd4ae6490591e4e20286513220_187)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i139c2cbd4ae6490591e4e20286513220_187)</u>. | <u>[44](#i139c2cbd4ae6490591e4e20286513220_187)</u> |
|  | <u>[Results of Operations](#i139c2cbd4ae6490591e4e20286513220_202)</u>. | <u>[47](#i139c2cbd4ae6490591e4e20286513220_202)</u> |
|  | <u>[Changes in Financial Condition](#i139c2cbd4ae6490591e4e20286513220_244)</u>. | <u>[54](#i139c2cbd4ae6490591e4e20286513220_244)</u> |
|  | <u>[Other Matters](#i139c2cbd4ae6490591e4e20286513220_250)</u>. | <u>[61](#i139c2cbd4ae6490591e4e20286513220_250)</u> |
| <u>[Item 3.](#i139c2cbd4ae6490591e4e20286513220_253)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i139c2cbd4ae6490591e4e20286513220_253)</u>. | <u>[62](#i139c2cbd4ae6490591e4e20286513220_253)</u> |
| <u>[Item 4.](#i139c2cbd4ae6490591e4e20286513220_259)</u> | <u>[Controls and Procedures](#i139c2cbd4ae6490591e4e20286513220_259)</u>. | <u>[62](#i139c2cbd4ae6490591e4e20286513220_259)</u> |
| **<u>[PART II – OTHER INFORMATION](#i139c2cbd4ae6490591e4e20286513220_262)</u>** | **<u>[PART II – OTHER INFORMATION](#i139c2cbd4ae6490591e4e20286513220_262)</u>** |  |
| <u>[Item 1.](#i139c2cbd4ae6490591e4e20286513220_265)</u> | <u>[Legal Proceedings](#i139c2cbd4ae6490591e4e20286513220_265)</u>. | <u>[63](#i139c2cbd4ae6490591e4e20286513220_265)</u> |
| <u>[Item 1A.](#i139c2cbd4ae6490591e4e20286513220_268)</u> | <u>[Risk Factors](#i139c2cbd4ae6490591e4e20286513220_268)</u>. | <u>[63](#i139c2cbd4ae6490591e4e20286513220_268)</u> |
| <u>[Item 2.](#i139c2cbd4ae6490591e4e20286513220_271)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i139c2cbd4ae6490591e4e20286513220_271)</u>. | <u>[64](#i139c2cbd4ae6490591e4e20286513220_271)</u> |
| <u>[Item 4.](#i139c2cbd4ae6490591e4e20286513220_274)</u> | <u>[Mine Safety Disclosures](#i139c2cbd4ae6490591e4e20286513220_274)</u>. | <u>[64](#i139c2cbd4ae6490591e4e20286513220_274)</u> |
| <u>[Item 5.](#i139c2cbd4ae6490591e4e20286513220_277)</u> | <u>[Other Information](#i139c2cbd4ae6490591e4e20286513220_277)</u>. | <u>[65](#i139c2cbd4ae6490591e4e20286513220_277)</u> |
| <u>[Item 6.](#i139c2cbd4ae6490591e4e20286513220_280)</u> | <u>[Exhibits](#i139c2cbd4ae6490591e4e20286513220_280)</u>. | <u>[65](#i139c2cbd4ae6490591e4e20286513220_280)</u> |
| **<u>[SIGNATURE](#i139c2cbd4ae6490591e4e20286513220_286)</u>** | **<u>[SIGNATURE](#i139c2cbd4ae6490591e4e20286513220_286)</u>** | <u>[66](#i139c2cbd4ae6490591e4e20286513220_286)</u> |

---

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Dow Inc. and Subsidiaries<br>The Dow Chemical Company and Subsidiaries**

This Quarterly Report on Form 10-Q is a combined report being filed by Dow Inc. and The Dow Chemical Company and its consolidated subsidiaries ("TDCC" and together with Dow Inc., "Dow" or the "Company") due to the parent/subsidiary relationship between Dow Inc. and TDCC. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Each of Dow Inc. and TDCC is filing information in this report on its own behalf and neither company makes any representation to the information relating to the other company.

**CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS**

Certain statements in this report are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would" and similar expressions, and variations or negatives of these words or phrases.

Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow's control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow's products; Dow's expenses, future revenues and profitability; any sanctions, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflicts between Russia and Ukraine and in the Middle East; capital requirements and need for and availability of financing; unexpected barriers in the development of technology, including with respect to Dow's contemplated capital and operating projects; Dow's ability to realize its commitment to carbon neutrality on the contemplated timeframe, including the completion and success of its integrated ethylene cracker and derivatives facility in Alberta, Canada; size of the markets for Dow's products and services and ability to compete in such markets; Dow's ability to develop and market new products and optimally manage product life cycles; the rate and degree of market acceptance of Dow's products; significant litigation and environmental matters and related contingencies and unexpected expenses; the success of competing technologies that are or may become available; the ability to protect Dow's intellectual property in the United States and abroad; developments related to contemplated restructuring activities and proposed divestitures or acquisitions such as workforce reduction, manufacturing facility and/or asset closure and related exit and disposal activities, and the benefits and costs associated with each of the foregoing; fluctuations in energy and raw material prices; management of process safety and product stewardship; changes in relationships with Dow's significant customers and suppliers; changes in public sentiment and political leadership; increased concerns about plastics in the environment and lack of a circular economy for plastics at scale; changes in consumer preferences and demand; changes in laws and regulations, political conditions, tariffs and trade policies, or industry development; global economic and capital markets conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business, logistics and supply disruptions; security threats, such as acts of sabotage, terrorism or war, including the ongoing conflicts between Russia and Ukraine and in the Middle East; weather events and natural disasters; disruptions in Dow's information technology networks and systems, including the impact of cyberattacks; risks related to Dow's separation from DowDuPont Inc. such as Dow's obligation to indemnify DuPont de Nemours, Inc. and/or Corteva, Inc. for certain liabilities; and any global and regional economic impacts of a pandemic or other public health-related risks and events on Dow's business.

Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" contained in Part II, Item 1A of this Quarterly Report on Form 10-Q and in Part I, Item 1A of the Company's Annual Report on Form 10-K for the year ended December 31, 2024. These are not the only risks and uncertainties that Dow faces. There may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not currently expect to have a material impact on its business. If any of those risks or uncertainties develops into an actual event, it could have a material adverse effect on Dow's business. Dow Inc. and TDCC assume no obligation to update or revise publicly any forward-looking statements whether because of new information, future events, or otherwise, except as required by securities and other applicable laws.

Dow's website and its content are not deemed incorporated by reference into this report.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**PART I – FINANCIAL INFORMATION**

**ITEM 1. FINANCIAL STATEMENTS**

**Dow Inc. and Subsidiaries**

**Consolidated Statements of Income**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions, except per share amounts (Unaudited) | *Jun 30,<br>2025* | *Jun 30,<br>2024* | *Jun 30,<br>2025* | *Jun 30,<br>2024* |
| Net sales | $10104 | $10915 | $20535 | $21680 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 9521 | 9591 | 19281 | 19079 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development expenses | 188 | 196 | 388 | 400 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 347 | 390 | 713 | 832 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 63 | 77 | 139 | 158 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and asset related charges - net | 591 |  | 799 | 45 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity in earnings (losses) of nonconsolidated affiliates | (30) | 26 | (50) | 43 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sundry income (expense) - net | 147 | 76 | 160 | 137 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | 39 | 42 | 67 | 107 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense and amortization of debt discount | 209 | 197 | 425 | 396 |
| Income (loss) before income taxes | (659) | 608 | (1033) | 1057 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes | 142 | 150 | 58 | 61 |
| Net income (loss) | (801) | 458 | (1091) | 996 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interests | 34 | 19 | 51 | 41 |
| Net income (loss) available for Dow Inc. common stockholders | $(835) | $439 | $(1142) | $955 |
| Per common share data: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings (loss) per common share - basic | $(1.18) | $0.62 | $(1.62) | $1.35 |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings (loss) per common share - diluted | $(1.18) | $0.62 | $(1.62) | $1.35 |
| Weighted-average common shares outstanding - basic | 709.5 | 703.8 | 708.2 | 704.1 |
| Weighted-average common shares outstanding - diluted | 709.5 | 705.3 | 708.2 | 705.5 |
| Depreciation | $538 | $488 | $1050 | $969 |
| Capital expenditures | $662 | $723 | $1347 | $1437 |

---

*See Notes to the Consolidated Financial Statements.*

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Dow Inc. and Subsidiaries**

**Consolidated Statements of Comprehensive Income**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions (Unaudited) | *Jun 30,<br>2025* | *Jun 30,<br>2024* | *Jun 30,<br>2025* | *Jun 30,<br>2024* |
| Net income (loss) | $(801) | $458 | $(1091) | $996 |
| Other comprehensive income (loss), net of tax |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Unrealized gains (losses) on investments | (22) | 61 | 10 | 55 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cumulative translation adjustments | 129 | (43) | 251 | (165) |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension and other postretirement benefit plans | 21 | 17 | 41 | 34 |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivative instruments | 2 | (6) | (18) | (28) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other comprehensive income (loss) | 130 | 29 | 284 | (104) |
| Comprehensive income (loss) | (671) | 487 | (807) | 892 |
| &nbsp;&nbsp;&nbsp;&nbsp;Comprehensive income attributable to noncontrolling interests, net of tax | 34 | 19 | 51 | 41 |
| Comprehensive income (loss) attributable to Dow Inc. | $(705) | $468 | $(858) | $851 |

---

*See Notes to the Consolidated Financial Statements.*

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Dow Inc. and Subsidiaries**

**Consolidated Balance Sheets**

---

| | | |
|:---|:---|:---|
| In millions, except share amounts (Unaudited) | *Jun 30,<br>2025* | *Dec 31,<br>2024* |
| **Assets** |  |  |
| Current Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $2399 | $2189 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts and notes receivable: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade (net of allowance for doubtful receivables - 2025: $72; 2024: $95) | 5426 | 4756 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 2228 | 2108 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 6701 | 6544 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 958 | 993 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets (variable interest entities restricted - 2025: $209; 2024: $55) | 17712 | 16590 |
| Investments |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment in nonconsolidated affiliates | 1262 | 1266 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other investments (investments carried at fair value - 2025: $2,033; 2024: $2,047) | 2788 | 3033 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncurrent receivables | 434 | 380 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investments | 4484 | 4679 |
| Property |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Property | 64860 | 62121 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Accumulated depreciation | 42384 | 40117 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net property (variable interest entities restricted - 2025: $2,380; 2024: $122) | 22476 | 22004 |
| Other Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 8698 | 8565 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other intangible assets (net of accumulated amortization - 2025: $5,660; 2024: $5,394) | 1606 | 1721 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 1246 | 1268 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax assets | 1424 | 1257 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred charges and other assets | 1345 | 1228 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other assets (variable interest entities restricted - 2025: $212; 2024: $15) | 14319 | 14039 |
| Total Assets | $58991 | $57312 |
| **Liabilities and Equity** |  |  |
| Current Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable | $149 | $135 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt due within one year | 401 | 497 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade | 4944 | 4847 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 1697 | 1694 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities - current | 325 | 318 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | 314 | 276 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued and other current liabilities | 2656 | 2521 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities (variable interest entities nonrecourse - 2025: $365; 2024: $24) | 10486 | 10288 |
| Long-Term Debt (variable interest entities nonrecourse - 2025: $176; 2024: $—) | 16247 | 15711 |
| Other Noncurrent Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax liabilities | 378 | 392 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension and other postretirement benefits - noncurrent | 4765 | 4736 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related liabilities - noncurrent | 665 | 713 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities - noncurrent | 982 | 984 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other noncurrent obligations | 6876 | 6637 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other noncurrent liabilities (variable interest entities nonrecourse - 2025: $329; 2024: $13) | 13666 | 13462 |
| Stockholders' Equity |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock (authorized 5,000,000,000 shares of $0.01 par value each;<br>issued 2025: 785,942,132 shares; 2024: 784,471,939 shares) | 8 | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 10758 | 9203 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 18766 | 20909 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (7826) | (8110) |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock at cost (2025: 77,097,981 shares; 2024: 80,859,145 shares) | (4475) | (4655) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dow Inc.'s stockholders' equity | 17231 | 17355 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interests | 1361 | 496 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total equity | 18592 | 17851 |
| Total Liabilities and Equity | $58991 | $57312 |

---

*See Notes to the Consolidated Financial Statements.*

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Dow Inc. and Subsidiaries**

**Consolidated Statements of Cash Flows**

---

| | | |
|:---|:---|:---|
| In millions (Unaudited) | *Six Months Ended* | *Six Months Ended* |
| In millions (Unaudited) | *Jun 30,<br>2025* | *Jun 30,<br>2024* |
| Operating Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | $(1091) | $996 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 1438 | 1402 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision (credit) for deferred income tax | (131) | 28 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings of nonconsolidated affiliates less than dividends received | 220 | 156 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net periodic pension benefit credit | (50) | (95) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension contributions | (76) | (63) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net gain on sales of assets, businesses and investments | (102) | (20) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring and asset related charges - net | 799 | 45 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other net loss | 104 | 155 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities, net of effects of acquired and divested companies: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts and notes receivable | (935) | (485) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (158) | (383) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (12) | 544 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets and liabilities, net | (372) | (988) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash provided by (used for) operating activities - continuing operations | (366) | 1292 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash provided by (used for) operating activities - discontinued operations | (13) | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash provided by (used for) operating activities | (379) | 1300 |
| Investing Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (1347) | (1437) |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment in gas field developments | (68) | (96) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales of property, businesses and consolidated companies, net of cash divested | 131 | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in and loans to nonconsolidated affiliates | (20) | (4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of investments | (205) | (1072) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales and maturities of investments | 552 | 1824 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other investing activities, net | (5) | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash used for investing activities | (962) | (765) |
| Financing Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in short-term notes payable | 48 | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of short-term debt greater than three months | 37 | 40 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on short-term debt greater than three months | (41) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of long-term debt | 1107 | 1396 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on long-term debt | (1114) | (183) |
| &nbsp;&nbsp;&nbsp;&nbsp;Collections on securitization programs, net of remittances | 18 | 21 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of treasury stock |  | (400) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of stock |  | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transaction financing, debt issuance and other costs | (85) | (11) |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee taxes paid for share-based payment arrangements | (16) | (38) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions to noncontrolling interests | (56) | (47) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of noncontrolling interests | 2433 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends paid to stockholders | (990) | (984) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash provided by (used for) financing activities | 1341 | (129) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 253 | (69) |
| Summary |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase in cash, cash equivalents and restricted cash | 253 | 337 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash, cash equivalents and restricted cash at beginning of period | 2263 | 3048 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash, cash equivalents and restricted cash at end of period | $2516 | $3385 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Restricted cash and cash equivalents, included in "Other current assets" | 117 | 44 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents at end of period | $2399 | $3341 |

---

*See Notes to the Consolidated Financial Statements.*

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Dow Inc. and Subsidiaries**

**Consolidated Statements of Equity**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions, except per share amounts (Unaudited) | *Jun 30,<br>2025* | *Jun 30,<br>2024* | *Jun 30,<br>2025* | *Jun 30,<br>2024* |
| Common Stock |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning and end of period | $8 | $8 | $8 | $8 |
| Additional Paid-in Capital |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | 9195 | 8942 | 9203 | 8880 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock issued/sold |  | 9 |  | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 109 | 112 | 196 | 199 |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock issuances - compensation and benefit plans | (85) | (51) | (180) | (118) |
| &nbsp;&nbsp;&nbsp;&nbsp;Sale of membership interest in Diamond Infrastructure Solutions (Note 17) | 1540 |  | 1540 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | (1) |  | (1) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | 10758 | 9012 | 10758 | 9012 |
| Retained Earnings |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | 20101 | 21796 | 20909 | 21774 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) available for Dow Inc. common stockholders | (835) | 439 | (1142) | 955 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends to stockholders | (496) | (491) | (990) | (984) |
| &nbsp;&nbsp;&nbsp;&nbsp;Common control transaction |  |  |  | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | (4) | (5) | (11) | (16) |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | 18766 | 21739 | 18766 | 21739 |
| Accumulated Other Comprehensive Loss |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | (7956) | (7814) | (8110) | (7681) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) | 130 | 29 | 284 | (104) |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | (7826) | (7785) | (7826) | (7785) |
| Treasury Stock |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | (4560) | (4507) | (4655) | (4374) |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock purchases |  | (200) |  | (400) |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock issuances - compensation and benefit plans | 85 | 51 | 180 | 118 |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | (4475) | (4656) | (4475) | (4656) |
| Dow Inc.'s stockholders' equity | 17231 | 18318 | 17231 | 18318 |
| Noncontrolling Interests | 1361 | 482 | 1361 | 482 |
| Total Equity | $18592 | $18800 | $18592 | $18800 |
| Dividends declared per share of common stock | $0.70 | $0.70 | $1.40 | $1.40 |

---

*See Notes to the Consolidated Financial Statements.*

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**The Dow Chemical Company and Subsidiaries**

**Consolidated Statements of Income**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions (Unaudited) | *Jun 30,<br>2025* | *Jun 30,<br>2024* | *Jun 30,<br>2025* | *Jun 30,<br>2024* |
| Net sales | $10104 | $10915 | $20535 | $21680 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 9520 | 9590 | 19279 | 19077 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development expenses | 188 | 196 | 388 | 400 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 347 | 390 | 713 | 832 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 63 | 77 | 139 | 158 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and asset related charges - net | 591 |  | 799 | 45 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity in earnings (losses) of nonconsolidated affiliates | (30) | 26 | (50) | 43 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sundry income (expense) - net | 163 | 74 | 176 | 135 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | 41 | 45 | 70 | 114 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense and amortization of debt discount | 209 | 197 | 425 | 396 |
| Income (loss) before income taxes | (640) | 610 | (1012) | 1064 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes | 142 | 150 | 58 | 61 |
| Net income (loss) | (782) | 460 | (1070) | 1003 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interests | 34 | 19 | 51 | 41 |
| Net income (loss) available for The Dow Chemical Company common stockholder | $(816) | $441 | $(1121) | $962 |
| Depreciation | $538 | $488 | $1050 | $969 |
| Capital expenditures | $662 | $723 | $1347 | $1437 |

---

*See Notes to the Consolidated Financial Statements.*

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**The Dow Chemical Company and Subsidiaries**

**Consolidated Statements of Comprehensive Income**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions (Unaudited) | *Jun 30,<br>2025* | *Jun 30,<br>2024* | *Jun 30,<br>2025* | *Jun 30,<br>2024* |
| Net income (loss) | $(782) | $460 | $(1070) | $1003 |
| Other comprehensive income (loss), net of tax |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Unrealized gains (losses) on investments | (22) | 61 | 10 | 55 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cumulative translation adjustments | 129 | (43) | 251 | (165) |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension and other postretirement benefit plans | 21 | 17 | 41 | 34 |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivative instruments | 2 | (6) | (18) | (28) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other comprehensive income (loss) | 130 | 29 | 284 | (104) |
| Comprehensive income (loss) | (652) | 489 | (786) | 899 |
| &nbsp;&nbsp;&nbsp;&nbsp;Comprehensive income attributable to noncontrolling interests, net of tax | 34 | 19 | 51 | 41 |
| Comprehensive income (loss) attributable to The Dow Chemical Company | $(686) | $470 | $(837) | $858 |

---

*See Notes to the Consolidated Financial Statements.*

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**The Dow Chemical Company and Subsidiaries**

**Consolidated Balance Sheets**

---

| | | |
|:---|:---|:---|
| In millions, except share amounts (Unaudited) | *Jun 30,<br>2025* | *Dec 31,<br>2024* |
| **Assets** |  |  |
| Current Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $2399 | $2189 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts and notes receivable: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade (net of allowance for doubtful receivables - 2025: $72; 2024: $95) | 5426 | 4756 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 2236 | 2116 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 6701 | 6544 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 921 | 960 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets (variable interest entities restricted - 2025: $209; 2024: $55) | 17683 | 16565 |
| Investments |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment in nonconsolidated affiliates | 1262 | 1266 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other investments (investments carried at fair value - 2025: $2,033; 2024: $2,047) | 2788 | 3033 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncurrent receivables | 427 | 374 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investments | 4477 | 4673 |
| Property |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Property | 64860 | 62121 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less accumulated depreciation | 42384 | 40117 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net property (variable interest entities restricted - 2025: $2,380; 2024: $122) | 22476 | 22004 |
| Other Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 8698 | 8565 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other intangible assets (net of accumulated amortization - 2025: $5,660; 2024: $5,394) | 1606 | 1721 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 1246 | 1268 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax assets | 1424 | 1257 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred charges and other assets | 1345 | 1228 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other assets (variable interest entities restricted - 2025: $212; 2024: $15) | 14319 | 14039 |
| Total Assets | $58955 | $57281 |
| **Liabilities and Equity** |  |  |
| Current Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable | $149 | $135 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt due within one year | 401 | 497 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade | 4944 | 4847 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 1714 | 1732 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities - current | 325 | 318 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | 314 | 276 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued and other current liabilities | 2535 | 2405 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities (variable interest entities nonrecourse - 2025: $365; 2024: $24) | 10382 | 10210 |
| Long-Term Debt (variable interest entities nonrecourse - 2025: $176; 2024: $—) | 16247 | 15711 |
| Other Noncurrent Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax liabilities | 378 | 392 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension and other postretirement benefits - noncurrent | 4765 | 4736 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related liabilities - noncurrent | 665 | 713 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities - noncurrent | 982 | 984 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other noncurrent obligations | 6737 | 6503 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other noncurrent liabilities (variable interest entities nonrecourse - 2025: $329: 2024: $13) | 13527 | 13328 |
| Stockholder's Equity |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock (authorized and issued 100 shares of $0.01 par value each) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 11362 | 9626 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 13902 | 16020 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (7826) | (8110) |
| &nbsp;&nbsp;&nbsp;&nbsp;The Dow Chemical Company's stockholder's equity | 17438 | 17536 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interests | 1361 | 496 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total equity | 18799 | 18032 |
| Total Liabilities and Equity | $58955 | $57281 |

---

*See Notes to the Consolidated Financial Statements.*

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**The Dow Chemical Company and Subsidiaries**

**Consolidated Statements of Cash Flows**

---

| | | |
|:---|:---|:---|
| In millions (Unaudited) | *Six Months Ended* | *Six Months Ended* |
| In millions (Unaudited) | *Jun 30,<br>2025* | *Jun 30,<br>2024* |
| Operating Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | $(1070) | $1003 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 1438 | 1402 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision (credit) for deferred income tax | (131) | 28 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings of nonconsolidated affiliates less than dividends received | 220 | 156 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net periodic pension benefit credit | (50) | (95) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension contributions | (76) | (63) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net gain on sales of assets, businesses and investments | (102) | (20) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring and asset related charges - net | 799 | 45 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other net loss | 105 | 156 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities, net of effects of acquired and divested companies: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts and notes receivable | (935) | (485) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (158) | (383) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (12) | 544 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets and liabilities, net | (412) | (988) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash provided by (used for) operating activities | (384) | 1300 |
| Investing Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (1347) | (1437) |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment in gas field developments | (68) | (96) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales of property, businesses and consolidated companies, net of cash divested | 131 | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in and loans to nonconsolidated affiliates | (20) | (4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of investments | (205) | (1072) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales and maturities of investments | 552 | 1824 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other investing activities, net | (5) | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash used for investing activities | (962) | (765) |
| Financing Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in short-term notes payable | 48 | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of short-term debt greater than three months | 37 | 40 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on short-term debt greater than three months | (41) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of long-term debt | 1107 | 1396 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on long-term debt | (1114) | (183) |
| &nbsp;&nbsp;&nbsp;&nbsp;Collections on securitization programs, net of remittances | 18 | 21 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of stock |  | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transaction financing, debt issuance and other costs | (85) | (11) |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee taxes paid for share-based payment arrangements | (16) | (38) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions to noncontrolling interests | (56) | (47) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of noncontrolling interests | 2433 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends paid to Dow Inc. | (985) | (1384) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash provided by (used for) financing activities | 1346 | (129) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 253 | (69) |
| Summary |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase in cash, cash equivalents and restricted cash | 253 | 337 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash, cash equivalents and restricted cash at beginning of period | 2263 | 3048 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash, cash equivalents and restricted cash at end of period | $2516 | $3385 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Restricted cash and cash equivalents, included in "Other current assets" | 117 | 44 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents at end of period | $2399 | $3341 |

---

*See Notes to the Consolidated Financial Statements.*

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**The Dow Chemical Company and Subsidiaries**

**Consolidated Statements of Equity**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions (Unaudited) | *Jun 30,<br>2025* | *Jun 30,<br>2024* | *Jun 30,<br>2025* | *Jun 30,<br>2024* |
| Common Stock |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning and end of period | $— | $— | $— | $— |
| Additional Paid-in Capital |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | 9713 | 9220 | 9626 | 9091 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of parent company stock - Dow Inc. |  | 9 |  | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 109 | 112 | 196 | 199 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sale of membership interest in Diamond Infrastructure Solutions (Note 17) | 1540 |  | 1540 |  |
| &nbsp;&nbsp;&nbsp;Balance at end of period | 11362 | 9341 | 11362 | 9341 |
| Retained Earnings |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | 15193 | 17214 | 16020 | 17495 |
| &nbsp;&nbsp;&nbsp; Net income (loss) available for The Dow Chemical Company common stockholder | (816) | 441 | (1121) | 962 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends to Dow Inc. | (470) | (686) | (985) | (1477) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | (5) | (5) | (12) | (16) |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | 13902 | 16964 | 13902 | 16964 |
| Accumulated Other Comprehensive Loss |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | (7956) | (7814) | (8110) | (7681) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) | 130 | 29 | 284 | (104) |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | (7826) | (7785) | (7826) | (7785) |
| The Dow Chemical Company's stockholder's equity | 17438 | 18520 | 17438 | 18520 |
| Noncontrolling Interests | 1361 | 482 | 1361 | 482 |
| Total Equity | $18799 | $19002 | $18799 | $19002 |

---

*See Notes to the Consolidated Financial Statements.*

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Dow Inc. and Subsidiaries**<br>**The Dow Chemical Company and Subsidiaries**<br>(Unaudited)<br>

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS**

**Table of Contents**

---

| | | |
|:---|:---|:---|
| **<u>Note</u>** | | **<u>Page</u>** |
| 1 | <u>[Consolidated Financial Statements](#i139c2cbd4ae6490591e4e20286513220_55)</u> | <u>[15](#i139c2cbd4ae6490591e4e20286513220_55)</u> |
| 2 | <u>[Recent Accounting Guidance](#i139c2cbd4ae6490591e4e20286513220_61)</u> | <u>[16](#i139c2cbd4ae6490591e4e20286513220_61)</u> |
| 3 | <u>[Revenue](#i139c2cbd4ae6490591e4e20286513220_70)</u> | <u>[17](#i139c2cbd4ae6490591e4e20286513220_70)</u> |
| 4 | <u>[Divestitures](#i139c2cbd4ae6490591e4e20286513220_73)</u> | <u>[18](#i139c2cbd4ae6490591e4e20286513220_73)</u> |
| 5 | <u>[Restructuring and Asset Related Charges - Net](#i139c2cbd4ae6490591e4e20286513220_79)</u> | <u>[19](#i139c2cbd4ae6490591e4e20286513220_79)</u> |
| 6 | <u>[Supplementary Information](#i139c2cbd4ae6490591e4e20286513220_88)</u> | <u>[21](#i139c2cbd4ae6490591e4e20286513220_88)</u> |
| 7 | <u>[Income Taxes](#i139c2cbd4ae6490591e4e20286513220_94)</u> | <u>[21](#i139c2cbd4ae6490591e4e20286513220_94)</u> |
| 8 | <u>[Earnings Per Share Calculations](#i139c2cbd4ae6490591e4e20286513220_97)</u> | <u>[22](#i139c2cbd4ae6490591e4e20286513220_97)</u> |
| 9 | <u>[Inventories](#i139c2cbd4ae6490591e4e20286513220_100)</u> | <u>[23](#i139c2cbd4ae6490591e4e20286513220_100)</u> |
| 10 | <u>[Nonconsolidated Affiliates](#i139c2cbd4ae6490591e4e20286513220_103)</u> | <u>[23](#i139c2cbd4ae6490591e4e20286513220_103)</u> |
| 11 | <u>[Goodwill](#i139c2cbd4ae6490591e4e20286513220_109)</u> | <u>[23](#i139c2cbd4ae6490591e4e20286513220_109)</u> |
| 12 | <u>[Transfers of Financial Assets](#i139c2cbd4ae6490591e4e20286513220_115)</u> | <u>[24](#i139c2cbd4ae6490591e4e20286513220_115)</u> |
| 13 | <u>[Notes Payable, Long Term Debt and Available Credit Facilities](#i139c2cbd4ae6490591e4e20286513220_121)</u> | <u>[25](#i139c2cbd4ae6490591e4e20286513220_121)</u> |
| 14 | <u>[Commitments and Contingencies](#i139c2cbd4ae6490591e4e20286513220_127)</u> | <u>[26](#i139c2cbd4ae6490591e4e20286513220_127)</u> |
| 15 | <u>[Leases](#i139c2cbd4ae6490591e4e20286513220_133)</u> | <u>[29](#i139c2cbd4ae6490591e4e20286513220_133)</u> |
| 16 | <u>[Accumulated Other Comprehensive Loss](#i139c2cbd4ae6490591e4e20286513220_142)</u> | <u>[30](#i139c2cbd4ae6490591e4e20286513220_142)</u> |
| 17 | <u>[Noncontrolling Interests](#i139c2cbd4ae6490591e4e20286513220_145)</u> | <u>[31](#i139c2cbd4ae6490591e4e20286513220_145)</u> |
| 18 | <u>[Pension and Other Postretirement Benefit Plans](#i139c2cbd4ae6490591e4e20286513220_148)</u> | <u>[32](#i139c2cbd4ae6490591e4e20286513220_148)</u> |
| 19 | <u>[Stock-Based Compensation](#i139c2cbd4ae6490591e4e20286513220_154)</u> | <u>[32](#i139c2cbd4ae6490591e4e20286513220_154)</u> |
| 20 | <u>[Financial Instruments](#i139c2cbd4ae6490591e4e20286513220_160)</u> | <u>[33](#i139c2cbd4ae6490591e4e20286513220_160)</u> |
| 21 | <u>[Fair Value Measurements](#i139c2cbd4ae6490591e4e20286513220_166)</u> | <u>[37](#i139c2cbd4ae6490591e4e20286513220_166)</u> |
| 22 | <u>[Variable Interest Entities](#i139c2cbd4ae6490591e4e20286513220_172)</u> | <u>[38](#i139c2cbd4ae6490591e4e20286513220_172)</u> |
| 23 | <u>[Segments and Geographic Regions](#i139c2cbd4ae6490591e4e20286513220_184)</u> | <u>[40](#i139c2cbd4ae6490591e4e20286513220_184)</u> |

---

**NOTE 1 – CONSOLIDATED FINANCIAL STATEMENTS**

**Basis of Presentation**

Dow Inc. is the direct parent company of The Dow Chemical Company and its consolidated subsidiaries ("TDCC" and together with Dow Inc., "Dow" or the "Company"). The unaudited interim consolidated financial statements of Dow Inc. and TDCC were prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and reflect all adjustments (including normal recurring accruals) which, in the opinion of management, are considered necessary for the fair presentation of the results for the periods presented. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2024 ("2024 10-K").

As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and considering that the financial statements and disclosures of each company are substantially similar, the companies are filing a combined report for this Quarterly Report on Form 10-Q. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Transactions between TDCC and Dow Inc. are treated as related party transactions for TDCC.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation, a wholly owned subsidiary of the Company. Additionally, the term "Diamond Infrastructure Solutions" means Dow InfraCo, LLC, an entity that owns and operates infrastructure assets at certain Dow locations on the U.S. Gulf Coast and became a consolidated variable interest entity effective May 1, 2025. See Notes 17 and 22 for additional information about Diamond Infrastructure Solutions.

**NOTE 2 – RECENT ACCOUNTING GUIDANCE**

**Recently Adopted Accounting Guidance**

In the fourth quarter of 2024, the Company adopted the annual and interim disclosure requirements of Accounting Standards Update ("ASU") 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures." The amendments expand a public business entity's segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), clarifying when an entity may report one or more additional measures to assess segment performance, requiring enhanced interim disclosures, providing new disclosure requirements for entities with a single reportable segment, and requiring other new disclosures. See Note 23 for applicable reportable segment disclosures required by this guidance.

**Accounting Guidance Issued But Not Adopted at June 30, 2025**

In December 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures," which is intended to enhance the transparency, decision usefulness and effectiveness of income tax disclosures. The amendments in this ASU require a public business entity to disclose a tabular tax rate reconciliation, using both percentages and currency, with specific categories. A public business entity is also required to provide a qualitative description of the states and local jurisdictions that make up the majority of the effect of the state and local income tax category and the net amount of income taxes paid, disaggregated by federal, state and foreign taxes and also disaggregated by individual jurisdictions. The amendments also remove certain disclosures that are no longer considered cost beneficial. The amendments are effective prospectively for annual periods beginning after December 15, 2024, and early adoption and retrospective application are permitted. The adoption of the ASU is not expected to have a material impact on the Company's consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses," which is intended to improve disclosures about a public business entity's expenses and address requests from investors for more detailed information about the types of expenses in commonly presented expense captions. Such information should allow investors to better understand an entity's performance, assess future cash flows, and compare performance over time and with other entities. The amendments will require public business entities to disclose in the notes to the financial statements, at each interim and annual reporting period, specific information about certain costs and expenses, including purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each expense caption presented on the face of the income statement, and the total amount of an entity's selling expenses. The amendments are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, and may be applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of adopting this guidance on the consolidated financial statements.

**SEC Final Rules Not Adopted at June 30, 2025**

In March 2024, the U.S. Securities and Exchange Commission ("SEC") adopted final rules under SEC Release Nos. 33-11275 and 34-99678, "The Enhancement and Standardization of Climate-Related Disclosures for Investors," which requires registrants to disclose certain climate-related information in registration statements and annual reports. As a large accelerated filer, most disclosure requirements would be effective for the Company beginning in the year ending December 31, 2025, with certain greenhouse gas emissions disclosures required for the year ending December 31, 2026. In April 2024, the SEC issued an order to stay the final rules until various legal challenges are resolved by the U.S. Court of Appeals for the Eighth Circuit ("Court of Appeals"). In March 2025, the SEC voted to end its defense of the final rules; however, the Court of Appeals may still rule on the matter.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**NOTE 3 – REVENUE**

**Revenue Recognition**

The majority of the Company's revenue is derived from product sales. The Company's revenue related to product sales was 98 percent and 97 percent for the three and six months ended June 30, 2025, respectively (97 percent and 98 percent for the three and six months ended June 30, 2024, respectively). The remaining sales were primarily related to the Company's insurance operations and licensing of patents and technologies. Product sales consist of sales of the Company's products to manufacturers and distributors. The Company considers order confirmations or purchase orders, which in some cases are governed by master supply agreements, to be contracts with a customer. The Company enters into licensing arrangements in which it licenses certain rights of its patents and technology to customers. Revenue from the Company's licenses for patents and technology is derived from sales-based royalties and licensing arrangements based on billing schedules established in each contract.

**Remaining Performance Obligations**

Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. At June 30, 2025, the Company had unfulfilled performance obligations of $762 million ($759 million at December 31, 2024) related to the licensing of technology. The Company expects revenue to be recognized for the remaining performance obligations over the next five years.

The Company has additional remaining performance obligations for product sales that have expected durations of one year or less, product sales of materials delivered through a pipeline for which the Company has elected the "right to invoice" practical expedient, and variable consideration attributable to royalties for licenses of patents and technology. The Company has received advance payments from customers related to long-term supply agreements that are deferred and recognized over the life of the contract, with remaining contract terms that range up to 18 years. The Company will have rights to future consideration for revenue recognized when product is delivered to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.

**Disaggregation of Revenue**

The Company disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See details in the tables below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Net Trade Sales by Segment and Business** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| &nbsp;&nbsp;&nbsp;Hydrocarbons & Energy | $1350 | $1447 | $2928 | $2914 |
| &nbsp;&nbsp;&nbsp;Packaging and Specialty Plastics | 3675 | 4068 | 7407 | 8031 |
| Packaging & Specialty Plastics | $5025 | $5515 | $10335 | $10945 |
| &nbsp;&nbsp;&nbsp;Industrial Solutions | $985 | $1040 | $2039 | $2068 |
| &nbsp;&nbsp;&nbsp;Polyurethanes & Construction Chemicals | 1797 | 1909 | 3594 | 3886 |
| &nbsp;&nbsp;&nbsp;Other | 4 | 2 | 8 | 5 |
| Industrial Intermediates & Infrastructure | $2786 | $2951 | $5641 | $5959 |
| &nbsp;&nbsp;&nbsp;Coatings & Performance Monomers | $864 | $928 | $1709 | $1813 |
| &nbsp;&nbsp;&nbsp;Consumer Solutions | 1265 | 1315 | 2491 | 2582 |
| Performance Materials & Coatings | $2129 | $2243 | $4200 | $4395 |
| Corporate | $164 | $206 | $359 | $381 |
| Total | $10104 | $10915 | $20535 | $21680 |

---

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Net Trade Sales by Geographic Region** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| U.S. & Canada | $3988 | $4191 | $8215 | $8321 |
| EMEAI <sup>1</sup> | 3272 | 3572 | 6546 | 7056 |
| Asia Pacific | 1737 | 1901 | 3595 | 3822 |
| Latin America | 1107 | 1251 | 2179 | 2481 |
| Total | $10104 | $10915 | $20535 | $21680 |

---

1. Europe, Middle East, Africa and India.

**Contract Assets and Liabilities**

The Company receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company's contractual right to consideration for completed performance obligations not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are recognized in revenue when the performance obligations are met. "Contract liabilities - current" primarily reflects deferred revenue from prepayments from customers for product to be delivered in 12 months or less and royalty payments that are deferred and will be recognized in 12 months or less. "Contract liabilities - noncurrent" includes advance payments that the Company has received from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract.

Revenue recognized in the first six months of 2025 from amounts included in contract liabilities at the beginning of the period was approximately $130 million (approximately $90 million in the first six months of 2024). In the first six months of 2025 and 2024, the amount of contract assets reclassified to receivables as a result of the right to the transaction consideration becoming unconditional was insignificant.

The following table summarizes contract assets and liabilities at June 30, 2025 and December 31, 2024:

---

| | | | |
|:---|:---|:---|:---|
| **Contract Assets and Liabilities** | *Balance Sheet Classification* | *Jun 30, 2025* | *Dec 31, 2024* |
| In millions | *Balance Sheet Classification* | *Jun 30, 2025* | *Dec 31, 2024* |
| Accounts and notes receivable - trade | Accounts and notes receivable - trade | $5426 | $4756 |
| Contract assets - noncurrent | Deferred charges and other assets | $— | $2 |
| Contract liabilities - current | Accrued and other current liabilities | $196 | $244 |
| Contract liabilities - noncurrent | Other noncurrent obligations | $1431 | $1480 |

---

**NOTE 4 – DIVESTITURES**

**Divestiture of Soil Fumigation Product Line**

On May 1, 2025, the Company sold Telone<sup>TM</sup>, a soil fumigation product line, and certain related assets, to TriCal Soil Solutions, Inc. ("TriCal"), a distributor and applicator of soil fumigation products, for cash proceeds of $121 million, net of costs to sell and other transaction expenses and subject to customary post-closing adjustments. Under the sale and purchase agreement, Dow retained ownership of the related production assets, which are leased to TriCal as part of a toll manufacturing arrangement that directs the Company to manufacture and deliver certain products to TriCal. These asset leases are classified as operating leases. Dow and TriCal have also entered into a site services agreement related to certain services the Company will provide to TriCal at its site in Stade, Germany. Divested assets included property with a net book value of $5 million and goodwill of $10 million. The Company recognized a pretax gain of $103 million in the second quarter of 2025, included in "Sundry income (expense) - net" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure.

The Company evaluated the divestiture of its soil fumigation product line and determined the divestiture did not represent a strategic shift that had a major effect on the Company's operations and financial results and did not qualify as an individually significant component of the Company. As a result, the divestiture is not reported as discontinued operations.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Divestiture of Investment in DowAksa**

On June 2, 2025, the Company announced it entered into a definitive agreement to sell its ownership interest in DowAksa Advanced Composites Holdings BV ("DowAksa"), a nonconsolidated affiliate, to its joint venture partner, Aksa Akrilik Kimya Sanayii A.Ş., for approximately $125 million. The Company is targeting to close the transaction in the third quarter of 2025, subject to regulatory approval and other closing conditions, and expects to record a gain on the transaction.

**NOTE 5 – RESTRUCTURING AND ASSET RELATED CHARGES - NET**

Charges for restructuring programs and other asset related charges, which include asset impairments, are recorded in "Restructuring and asset related charges - net" in the consolidated statements of income. For additional information on the Company's 2023 Restructuring Program and other asset related charges, see Note 5 to the Consolidated Financial Statements included in the 2024 10-K.

*2025 Restructuring Program*

On January 27, 2025, the Dow Inc. Board of Directors ("Board") approved targeted actions to further achieve the Company's cost reduction initiatives in response to ongoing macroeconomic uncertainty, while reinforcing its long-term competitiveness across the economic cycle. The actions include a workforce reduction of approximately 1,500 roles. As a result of these actions, in the first quarter of 2025 the Company recorded pretax charges of $207 million for severance and related benefits costs, included in "Restructuring and asset related charges - net" in the consolidated statements of income, related to Corporate. These actions are expected to be substantially complete by the end of 2026.

On June 30, 2025, the Board approved restructuring actions to rationalize the Company's global asset footprint, including certain actions identified as part of the Company's previously announced strategic review of its European assets and certain corporate and other assets, and to enhance the Company's competitiveness over the economic cycle. The program includes asset write-down and write-off charges, severance and related benefit costs and other exit and disposal costs. As a result of these actions, in the second quarter of 2025 the Company recorded pretax restructuring charges of $591 million, consisting of severance and related benefit costs of $154 million, asset write-downs and write-offs of $334 million and costs associated with exit and disposal activities of $103 million. The impact of these charges is shown as "Restructuring and asset related charges - net" in the consolidated statements of income. See Note 21 for additional information on nonrecurring fair value measurements. The following table summarizes the activities related to the 2025 Restructuring Program, including segment information:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **2025 Restructuring Program** | *Severance and Related Benefit Costs* | *Asset Write-downs and Write-offs* | *Costs Associated with Exit and Disposal Activities* | *Total* |
| In millions | *Severance and Related Benefit Costs* | *Asset Write-downs and Write-offs* | *Costs Associated with Exit and Disposal Activities* | *Total* |
| &nbsp;&nbsp;Corporate | $207 | $— | $— | $207 |
| Total restructuring charges | $207 | $— | $— | $207 |
| Reserve balance at Mar 31, 2025 | $207 | $— | $— | $207 |
| &nbsp;&nbsp;Packaging & Specialty Plastics | $— | $81 | $77 | $158 |
| &nbsp;&nbsp;Industrial Intermediates & Infrastructure |  | 63 | 26 | 89 |
| &nbsp;&nbsp;Performance Materials & Coatings |  | 147 |  | 147 |
| &nbsp;&nbsp;Corporate | 154 | 43 |  | 197 |
| Total restructuring charges | $154 | $334 | $103 | $591 |
| Charges against the reserve <sup>1</sup> |  | (334) | (103) | (437) |
| Cash payments | (16) |  |  | (16) |
| Reserve balance at Jun 30, 2025 | $345 | $— | $— | $345 |

---

1. Costs associated with exit and disposal activities relate to asset retirement obligations.

At June 30, 2025, $178 million of the restructuring reserve balance was included in "Accrued and other current liabilities" and $167 million was included in "Other noncurrent obligations" in the consolidated balance sheets.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

The Company recorded pretax restructuring charges of $798 million inception-to-date under the 2025 Restructuring Program, consisting of severance and related benefit costs of $361 million, asset write-downs and write-offs of $334 million and costs associated with exit and disposal activities of $103 million.

Restructuring implementation costs, primarily decommissioning and demolition activities related to asset actions and costs associated with the Company's restructuring actions, are expected to result in additional cash expenditures of approximately $225 million. Restructuring implementation costs totaled $5 million for the three and six months ended June 30, 2025.

*Severance and Related Benefit Costs*

Severance benefits are provided to employees primarily under Dow's ongoing benefit arrangements and are accrued against the Corporate segment once management commits to a plan of termination. The 2025 Restructuring Program included charges for severance and related benefit costs of $361 million. At June 30, 2025, $16 million in severance payments had been made.

*Asset Write-downs and Write-offs*

The 2025 Restructuring Program included charges related to the write-down and write-off of assets totaling $334 million. Details regarding the asset write-downs and write-offs are as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Packaging & Specialty Plastics recorded a charge to rationalize its global asset footprint by shutting down an ethylene facility in Böhlen, Germany by the end of 2027.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Industrial Intermediates & Infrastructure recorded a charge to primarily rationalize its global asset footprint by shutting down certain chlor-alkali and vinyl assets in Schkopau, Germany by the end of 2027.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Performance Materials & Coatings recorded a charge to primarily rationalize its global asset footprint by shutting down a basics siloxanes plant in Barry, United Kingdom by mid-year 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Corporate recorded charges related to the write-down of certain Company owned and leased non-manufacturing facilities and other assets.

*Costs Associated with Exit and Disposal Activities*

The Company accrued additional asset retirement obligations of $111 million in the second quarter of 2025 associated with the asset shutdowns noted above, resulting in charges of $103 million after the impact of estimated recoveries. See Note 14 for additional information related to the Company's asset retirement obligations. It is reasonably possible the Company will incur approximately $60 million of future charges related to costs associated with exit and disposal activities.

In addition, the Company is assessing potential environmental remediation activities associated with the asset actions noted above, which could result in additional charges and cash payments in the future. The Company intends to continue operating other assets at the sites impacted by these actions.

*2023 Restructuring Program*

Actions related to the restructuring program approved by the Board on January 25, 2023, were complete at the end of the second quarter of 2025. In the first quarter of 2025, the Company recorded an additional pretax restructuring charge of $5 million for asset write-downs and write-offs and an asset related credit adjustment of $4 million, included in "Restructuring and asset related charges - net" in the consolidated statements of income, related to Industrial Intermediates & Infrastructure. See Note 21 for additional information on nonrecurring fair value measurements. Restructuring implementation and efficiency costs were zero and $50 million for the three and six months ended June 30, 2025, respectively ($56 million and $102 million for the three and six months ended June 30, 2024, respectively).

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**NOTE 6 – SUPPLEMENTARY INFORMATION**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Dow Inc. Sundry Income (Expense) – Net** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| Non-operating pension and other postretirement benefit plan net credits <sup>1</sup> | $36 | $61 | $74 | $122 |
| Foreign exchange gains (losses) <sup>2</sup> | 4 | (12) | 11 | (35) |
| Gain (loss) on sales of other assets and investments | (2) | 10 | (5) | 19 |
| Gain on divestiture of soil fumigation product line <sup>3</sup> | 103 |  | 103 |  |
| Gain (loss) on early extinguishment of debt <sup>4</sup> |  | 5 | (60) | 5 |
| Indemnification and other transaction related costs <sup>5</sup> | (17) | 1 | (17) | 1 |
| Other - net | 23 | 11 | 54 | 25 |
| Total sundry income (expense) – net | $147 | $76 | $160 | $137 |

---

1. See Note 18 for additional information.

2. Foreign exchange losses for the three months ended June 30, 2024 relate primarily to exposures in the Argentine peso, while losses in the six months ended June 30, 2024 relate primarily to exposures in the Egyptian pound and Argentine peso.

3. See Note 4 for additional information.

4. See Note 13 for additional information.

5. Primarily related to charges associated with agreements entered into with DuPont de Nemours, Inc. and Corteva, Inc. as part of the separation and distribution.

Sundry income (expense) - net for TDCC for the three and six months ended June 30, 2025 and 2024 is substantially the same as that of Dow Inc. and, therefore, Sundry income (expense) - net for TDCC is not disclosed separately.

**Other Investments**

The Company has investments in company-owned life insurance policies, which are recorded at their cash surrender value as of each balance sheet date, as provided below:

---

| | | |
|:---|:---|:---|
| **Investments in Company-Owned Life Insurance** | *Jun 30, 2025* | *Dec 31, 2024* |
| In millions | *Jun 30, 2025* | *Dec 31, 2024* |
| Gross cash value | $535 | $558 |
| Less: Existing drawdowns <sup>1</sup> | 200 |  |
| Less: Accrued interest on drawdowns <sup>2</sup> | 3 |  |
| Investments in company-owned life insurance <sup>3</sup> | $332 | $558 |

---

1. Classified as "Proceeds from sales and maturities of investments" in the consolidated statements of cash flows.

2. Included in "Sundry income (expense) - net" in the consolidated statements of income.

3. Classified as "Other investments" in the consolidated balance sheets.

**Supplier Finance Program**

The Company facilitates a supply chain financing ("SCF") program in the ordinary course of business in order to extend payment terms with vendors. Under the terms of this program, a vendor can voluntarily enter into an agreement with a participating financial intermediary to sell its receivables due from the Company. The vendor receives payment from the financial intermediary, and the Company pays the financial intermediary on the terms originally negotiated with the vendor, which generally range from 90 to 120 days. The vendor negotiates the terms of the agreements directly with the financial intermediary and the Company is not a party to that agreement. The financial intermediary may allow the participating vendor to utilize the Company's creditworthiness in establishing credit spreads and associated costs, which may provide the vendor with more favorable terms than they would be able to secure on their own. The Company does not provide guarantees related to the SCF program. At June 30, 2025, outstanding obligations confirmed as valid under the SCF program were $306 million ($291 million at December 31, 2024), included in "Accounts payable – Trade" in the consolidated balance sheets.

**NOTE 7 – INCOME TAXES**

As the financial statements for Dow Inc. and TDCC are substantially similar, including the provision for income taxes, the following income tax discussion does not include reference to TDCC's provision for income taxes or its effective tax rate.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

The Company's effective tax rate fluctuates based on, among other factors, where income is earned, the level of income relative to tax attributes and the level of equity earnings, since most earnings from the Company's equity method investments are taxed at the joint venture level.

In the second quarter of 2025, the Company reported a provision for income taxes of $142 million, resulting in a negative effective tax rate of 21.5 percent ($150 million in the second quarter of 2024, resulting in an effective tax rate of 24.7 percent). For the first six months of 2025, the Company reported a provision for income taxes of $58 million, resulting in a negative effective tax rate of 5.6 percent ($61 million for the first six months of 2024, resulting in an effective tax rate of 5.8 percent).

The provision for income taxes for the three and six months ended June 30, 2025 was unfavorably impacted by the recording of valuation allowances in certain foreign jurisdictions of $242 million as well as losses attributable to jurisdictions for which no tax benefit can be recognized, and a tax credit of $89 million related to the sale of a portion of the Company's membership interest in its wholly owned subsidiary, Diamond Infrastructure Solutions, resulting in a negative effective tax rate for both periods. See Note 17 for additional information related to the Diamond Infrastructure Solutions transaction. In the first quarter of 2024, the Company recorded a tax credit of $194 million related to a reassessment of interest and penalties on a tax matter in a foreign jurisdiction, resulting in a reduced effective tax rate for the first six months of 2024.

**NOTE 8 – EARNINGS PER SHARE CALCULATIONS**

The following tables provide earnings per share calculations for Dow Inc. for the three and six months ended June 30, 2025 and 2024. Earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Net Income (Loss) for Earnings Per Share Calculations** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |  |  |  |  |  |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |  |  |  |  |  |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* | Net income (loss) | $(801) | $458 | $(1091) | $996 |
| Net income attributable to noncontrolling interests | 34 | 19 | 51 | 41 |  |  |  |  |  |
| Net income attributable to participating securities <sup>1</sup> | 4 | 3 | 7 | 6 |  |  |  |  |  |
| Net income (loss) attributable to common stockholders | $(839) | $436 | $(1149) | $949 |  |  |  |  |  |

---

1. Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Earnings (Loss) Per Share - Basic and Diluted** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |  |  |  |  |  |
| Dollars per share | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |  |  |  |  |  |
| Dollars per share | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* | Earnings (loss) per common share - basic | $(1.18) | $0.62 | $(1.62) | $1.35 |
| Earnings (loss) per common share - diluted | $(1.18) | $0.62 | $(1.62) | $1.35 |  |  |  |  |  |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Share Count Information** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |  |  |  |  |  |
| Shares in millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |  |  |  |  |  |
| Shares in millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* | Weighted-average common shares outstanding - basic | 709.5 | 703.8 | 708.2 | 704.1 |
| Plus dilutive effect of equity compensation plans <sup>1</sup> |  | 1.5 |  | 1.4 |  |  |  |  |  |
| Weighted-average common shares outstanding - diluted | 709.5 | 705.3 | 708.2 | 705.5 |  |  |  |  |  |
| Stock units excluded from EPS calculations <sup>2</sup> | 19.6 | 9.4 | 17.2 | 9.1 |  |  |  |  |  |

---

1. The three and six months ended June 30, 2025 reflect a net loss and, as such, the basic share count was used for purposes of calculating earnings per share on a diluted basis.

2. These outstanding stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**NOTE 9 – INVENTORIES**

The following table provides a breakdown of inventories:

---

| | | |
|:---|:---|:---|
| **Inventories** | *Jun 30, 2025* | *Dec 31, 2024* |
| In millions | *Jun 30, 2025* | *Dec 31, 2024* |
| Finished goods | $3764 | $3773 |
| Work in process | 1365 | 1323 |
| Raw materials | 845 | 822 |
| Supplies | 1137 | 1039 |
| Total | $7111 | $6957 |
| Adjustment of inventories to the LIFO basis | (410) | (413) |
| Total inventories | $6701 | $6544 |

---

**NOTE 10 – NONCONSOLIDATED AFFILIATES**

For additional information on the Company's nonconsolidated affiliates, see Note 11 to the Consolidated Financial Statements included in the 2024 10-K.

The Company's investments in companies accounted for using the equity method ("nonconsolidated affiliates"), by classification in the consolidated balance sheets are shown in the following table:

---

| | | |
|:---|:---|:---|
| **Investments in Nonconsolidated Affiliates** | *Jun 30, 2025* | *Dec 31, 2024* |
| In millions | *Jun 30, 2025* | *Dec 31, 2024* |
| Investment in nonconsolidated affiliates | $1262 | $1266 |
| Other noncurrent obligations | (792) | (568) |
| Net investment in nonconsolidated affiliates | $470 | $698 |

---

At June 30, 2025, the Company had a negative investment balance in Sadara Chemical Company of $717 million included in "Other noncurrent obligations" (negative $517 million at December 31, 2024) in the consolidated balance sheets. The increased negative investment in Sadara Chemical Company at June 30, 2025 is due to equity losses generated during the first six months of 2025 driven by the impact of challenging macroeconomic conditions.

At June 30, 2025, the Company had a negative investment balance in EQUATE Petrochemical Company K.S.C.C of $75 million included in "Other noncurrent obligations" (negative $51 million at December 31, 2024) in the consolidated balance sheets. The increase in the negative investment was driven by dividends distributed to shareholders, partially offset by equity earnings in the first six months of 2025.

**NOTE 11 – GOODWILL**

The following table shows changes in the carrying amount of goodwill by reportable segment:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Goodwill** | *Packaging & Specialty Plastics* | *Industrial Intermediates & Infrastructure* | *Performance Materials & Coatings* | *Total* |
| In millions | *Packaging & Specialty Plastics* | *Industrial Intermediates & Infrastructure* | *Performance Materials & Coatings* | *Total* |
| Net goodwill at Dec 31, 2024 | $5118 | $1092 | $2355 | $8565 |
| Divestiture |  | (10) |  | (10) |
| Foreign currency impact | 12 | 5 | 126 | 143 |
| Net goodwill at Jun 30, 2025 | $5130 | $1087 | $2481 | $8698 |

---

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

*Goodwill Impairment Testing*

During the second quarter of 2025, the Company identified potential indicators of goodwill impairment due to announced restructuring actions and ongoing macroeconomic challenges. As a result, the Company evaluated whether the fair value of any reporting unit may be less than its carrying amount. This assessment indicated that the Consumer Solutions reporting unit, part of the Performance Materials & Coatings segment, required an interim quantitative goodwill impairment test as of June 30, 2025. The test concluded that no goodwill impairment existed, as the fair value of the Consumer Solutions reporting unit exceeded its carrying value. Fair value was estimated using a discounted cash flow model that incorporated current market conditions and the anticipated effects of the restructuring actions. Key assumptions included projected revenue growth, discount rate, tax rate, terminal value, currency exchange rates, and long-term raw material and energy price forecasts.

**NOTE 12 – TRANSFERS OF FINANCIAL ASSETS**

**Accounts Receivable Programs**

The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States and a committed facility in Europe (collectively, "the Programs"), which are set to expire in November 2025. Under the terms of the Programs, the Company may sell certain eligible trade accounts receivable at any point in time, up to $900 million for the U.S. committed facility and up to €500 million for the Europe committed facility. Under the terms of the Programs, the Company continues to service the receivables from the customer, but retains no interest in the receivables, and remits payment to the financial institutions. Losses on transfers of receivables were insignificant for the three and six months ended June 30, 2025 and 2024. The Company also provides a guarantee to the financial institutions for the creditworthiness and collection of the receivables in satisfaction of the facility. See Note 14 for additional information related to guarantees.

The Company has access to accounts receivable discounting facilities that cover certain receivables generated from sales in EMEAI, Asia Pacific and Canada (collectively, "the Facilities"). Under the terms of the Facilities, the Company retains no interest in the transferred receivables once sold and receivables are transferred with limited recourse. The Company continues to service the receivables from the customer and remits payment to the Facilities. Losses on transfers of receivables were insignificant for the three and six months ended June 30, 2025 and 2024.

The following table provides a summary of cash flows related to the Programs and the Facilities for the three and six months ended June 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Cash Flows Related to Transfers of Accounts Receivable** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| Proceeds received from new transfers | $24 | $623 | $538 | $1050 |

---

The following table provides the balances related to the Programs and the Facilities at June 30, 2025 and December 31, 2024:

---

| | | |
|:---|:---|:---|
| **Balances Related to Transfers of Accounts Receivable** | *Jun 30, 2025* | *Dec 31, 2024* |
| In millions | *Jun 30, 2025* | *Dec 31, 2024* |
| Balance outstanding | $34 | $287 |
| Accounts receivable derecognized | $5 | $278 |
| Amounts recognized in the consolidated balance sheets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued and other current liabilities <sup>1</sup> | $29 | $9 |

---

1. Represents amounts collected from customers and not yet remitted by the Company.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**NOTE 13 – NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES**

---

| | | |
|:---|:---|:---|
| **Notes Payable** | *Jun 30, 2025* | *Dec 31, 2024* |
| In millions | *Jun 30, 2025* | *Dec 31, 2024* |
| Notes payable to banks and other lenders | $149 | $135 |
| Period-end average interest rates | 28.81% | 36.03% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Long-Term Debt** | *2025 Average Rate* | *Jun 30, 2025* | *2024 Average Rate* | *Dec 31, 2024* |
| In millions | *2025 Average Rate* | *Jun 30, 2025* | *2024 Average Rate* | *Dec 31, 2024* |
| Promissory notes and debentures: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Final maturity 2025 | 4.55% | $208 | 5.63% | $333 |
| &nbsp;&nbsp;&nbsp;Final maturity 2028 | 4.80% | 600 | 4.80% | 600 |
| &nbsp;&nbsp;&nbsp;Final maturity 2029 <sup>1</sup> | 7.53% | 951 | 7.58% | 1368 |
| &nbsp;&nbsp;&nbsp;Final maturity 2030 | 2.10% | 818 | 2.10% | 818 |
| &nbsp;&nbsp;&nbsp;Final maturity 2031 and thereafter <sup>1</sup> | 5.41% | 10223 | 5.37% | 9192 |
| Other facilities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency notes and loans, various rates and maturities <sup>1</sup> | 2.11% | 2250 | 2.01% | 2540 |
| &nbsp;&nbsp;&nbsp;InterNotes<sup>®</sup>, varying maturities through 2053 | 4.53% | 756 | 4.31% | 661 |
| &nbsp;&nbsp;&nbsp;&nbsp;Medium-term notes, maturity 2025 | 4.75% | 1 | 4.75% | 1 |
| &nbsp;&nbsp;&nbsp;Finance lease obligations <sup>2</sup> |  | 1066 |  | 939 |
| Unamortized debt discount and issuance costs |  | (225) |  | (244) |
| Long-term debt due within one year <sup>3</sup> |  | (401) |  | (497) |
| Long-term debt |  | $16247 |  | $15711 |

---

1. Cost includes net fair value hedge adjustment gains of $43 million at June 30, 2025 ($9 million at December 31, 2024). See Note 20 for additional information.

2. See Note 15 for additional information.

3. Presented net of current portion of unamortized debt issuance costs.

---

| | |
|:---|:---|
| **Maturities of Long-Term Debt for Next Five Years at Jun 30, 2025** | **Maturities of Long-Term Debt for Next Five Years at Jun 30, 2025** |
| In millions | In millions |
| 2025 | $317 |
| 2026 | $152 |
| 2027 | $771 |
| 2028 | $742 |
| 2029 | $1054 |
| 2030 | $953 |

---

**2025 Activity** 

In the first quarter of 2025, the Company completed debt neutral liability management activities. The Company issued $1 billion of senior unsecured notes. The offering included $400 million aggregate principal amount of 5.35 percent notes due 2035 and $600 million aggregate principal amount of 5.95 percent notes due 2055. The Company used the proceeds to complete cash tender offers for certain debt securities. In total, $943 million aggregate principal amount was tendered and retired. As a result, the Company recognized a pretax loss of $60 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income, related to Corporate.

In the first six months of 2025, the Company issued an aggregate principal amount of $107 million of InterNotes<sup>®</sup>. Additionally, the Company repaid $125 million of long-term debt at maturity.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Available Credit Facilities**

The following table summarizes the Company's credit facilities:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Committed and Available Credit Facilities at Jun 30, 2025** | **Committed and Available Credit Facilities at Jun 30, 2025** | **Committed and Available Credit Facilities at Jun 30, 2025** | **Committed and Available Credit Facilities at Jun 30, 2025** | **Committed and Available Credit Facilities at Jun 30, 2025** |
| In millions | *Committed Credit* | *Available Credit* | *Maturity Date* | *Interest* |
| Five Year Competitive Advance and Revolving Credit Facility | $5000 | $5000 | June 2030 | Floating rate |
| Bilateral Revolving Credit Facility | 200 | 200 | September 2025 | Floating rate |
| Bilateral Revolving Credit Facility | 175 | 175 | September 2025 | Floating rate |
| Bilateral Revolving Credit Facility | 300 | 300 | November 2025 | Floating rate |
| Bilateral Revolving Credit Facility | 300 | 300 | February 2026 | Floating rate |
| Bilateral Revolving Credit Facility | 100 | 100 | March 2026 | Floating rate |
| Bilateral Revolving Credit Facility | 375 | 375 | October 2026 | Floating rate |
| Bilateral Revolving Credit Facility | 150 | 150 | November 2026 | Floating rate |
| Bilateral Revolving Credit Facility | 200 | 200 | November 2026 | Floating rate |
| Bilateral Revolving Credit Facility | 250 | 250 | March 2027 | Floating rate |
| Bilateral Revolving Credit Facility | 100 | 100 | May 2027 | Floating rate |
| Bilateral Revolving Credit Facility | 350 | 350 | June 2027 | Floating rate |
| Bilateral Revolving Credit Facility | 200 | 200 | September 2027 | Floating rate |
| Bilateral Revolving Credit Facility | 100 | 100 | October 2027 | Floating rate |
| Bilateral Revolving Credit Facility | 100 | 100 | November 2027 | Floating rate |
| Bilateral Revolving Credit Facility | 100 | 100 | March 2028 | Floating rate |
| Bilateral Revolving Credit Facility | 100 | 100 | March 2028 | Floating rate |
| Bilateral Revolving Credit Facility | 300 | 300 | May 2028 | Floating rate |
| Total committed and available credit facilities | $8400 | $8400 |  |  |

---

**Debt Covenants and Default Provisions**

There were no material changes to the debt covenants and default provisions related to the Company's outstanding long-term debt and primary, private credit agreements in the first six months of 2025. For additional information on the Company's debt covenants and default provisions, see Note 14 to the Consolidated Financial Statements included in the 2024 10-K.

**NOTE 14 – COMMITMENTS AND CONTINGENCIES**

A summary of the Company's commitments and contingencies can be found in Note 15 to the Consolidated Financial Statements included in the 2024 10-K, which is incorporated by reference herein.

**Environmental Matters**

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. At June 30, 2025, the Company had accrued obligations of $1,071 million for probable environmental remediation and restoration costs ($1,113 million at December 31, 2024), including $224 million for the remediation of Superfund sites ($234 million at December 31, 2024). This is management's best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately two times that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company's results of operations, financial condition and cash flows. It is the opinion of the Company's management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the Company's results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. As new or additional information becomes available and/or certain spending trends become known, management will evaluate such information in determination of the current estimate of environmental liability.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Litigation**

***Asbestos-Related Matters of Union Carbide Corporation***

Each quarter, Union Carbide reviews asbestos-related claims filed, settled and dismissed, as well as average settlement and resolution costs by disease category. Union Carbide also considers additional quantitative and qualitative factors such as the nature of pending claims, trial experience of Union Carbide and other asbestos defendants, current spending for defense and processing costs, significant appellate rulings and legislative developments, trends in the tort system, and their respective effects on expected future resolution costs. Union Carbide's management considers these factors in conjunction with the most recent actuarial study and determines whether a change in the estimate is warranted. Based on Union Carbide's review of 2025 activity, it was determined that no adjustment to the accrual was required at June 30, 2025.

Union Carbide's total asbestos-related liability for pending and future claims and defense and processing costs was $745 million at June 30, 2025 ($791 million at December 31, 2024). At June 30, 2025, approximately 26 percent of the recorded claim liability related to pending claims and approximately 74 percent related to future claims.

***Legacy Matters***

*Groundwater Matters*

The Company is the subject of various complaints related to alleged groundwater contamination based on decades-old sales and applications of certain agricultural chemical products ("Groundwater Matters"). The costs associated with these Groundwater Matters were previously covered by insurance policies that have since been depleted. In the first quarter of 2023, the Company completed a study of certain Groundwater Matters related to wells deemed to be probable and estimable based on the public reporting of sampling data and historical information to develop a reasonable estimate of the cost of pending and future claims and accrued a charge based on the estimate. In the second quarter of 2025, the Company completed a reassessment study of these Groundwater Matters based on current known factors, resulting in a reduced estimate of the cost of pending and future claims. As a result, the Company recorded a pretax credit of $106 million, included in "Cost of sales" in the consolidated statements of income and related to Corporate. In the second quarter of 2025, the Company settled a separate claim related to Groundwater Matters at a water storage district, resulting in a pretax charge of $64 million, included in "Cost of sales" in the consolidated statements of income and related to Corporate.

At June 30, 2025, the total liability related to settled claims and the probable and estimable settlement of all alleged Groundwater Matters was $99 million ($155 million at December 31, 2024), which was included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.

The Company is also the subject of other groundwater contamination complaints, including claims related to 1,4-dioxane. The Company continues to defend itself in this litigation and it has determined that the Company's exposure to liability, if any, is not probable or estimable at June 30, 2025.

*Other Legacy Matters*

On October 10, 2024, the Company executed a settlement agreement related to arbitration for historical product claims from a divested business. As a result, the Company recorded a pretax charge of $75 million in the third quarter of 2024, which was paid in the fourth quarter of 2024. Arbitration on the matter was concluded on March 11, 2025, and, as a result, the Company recorded an additional pretax charge of $98 million in the first quarter of 2025, which is included in "Cost of sales" in the consolidated statements of income, related to Corporate, and was paid in the second quarter of 2025.

**Gain Contingency - Dow v. Nova Chemicals Corporation Ethylene Asset Matter**

In 2019, The Court of King's Bench of Alberta, Canada ("Court") signed a judgment ordering Nova Chemicals Corporation ("Nova") to pay the Company $1.43 billion Canadian dollars (equivalent to approximately $1.08 billion U.S. dollars) for damages the Company incurred through 2012 related to the companies' jointly-owned ethylene asset in Joffre, Alberta, Canada, for which the Company received payment in October 2019 and March 2020. At June 30, 2025, $201 million ($201 million at December 31, 2024) was included in "Other noncurrent obligations" in the Company's consolidated balance sheets related to the disputed portion of the damages judgment.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

On June 10, 2025, the Court signed a separate judgment ordering Nova to pay the Company an additional amount of $1.62 billion Canadian dollars (equivalent to approximately $1.2 billion U.S. dollars) for damages the Company incurred through June 2018, which had not been previously quantified. The Court again found that Nova failed to operate the companies' jointly-owned ethylene asset at full capacity during this time and, furthermore, that Nova violated several contractual agreements related to the Company receiving its share of the asset's ethylene production, depriving the Company of millions of pounds of ethylene. The award includes interest to April 7, 2025, but excludes subsequent interest and legal costs. While the judgment is subject to appeal, payment of the judgment is required and Dow expects to receive the additional cash proceeds by the end of 2025.

**Guarantees**

The following table provides a summary of the final expiration, maximum future payments and recorded liability included in the consolidated balance sheets for guarantees:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Guarantees** | *Jun 30, 2025* | *Jun 30, 2025* | *Jun 30, 2025* | *Dec 31, 2024* | *Dec 31, 2024* | *Dec 31, 2024* |
| In millions | *Final<br>Expiration* | *Maximum<br>Future Payments* | *Recorded Liability* | *Final<br>Expiration* | *Maximum<br>Future Payments* | *Recorded Liability* |
| Guarantees | 2038 | $1229 | $144 | 2038 | $1456 | $155 |

---

Guarantees arise during the ordinary course of business from relationships with customers, accounts receivable facilities and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company to make payments to the beneficiary of the guarantee. The majority of the Company's guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than one year to 13 years. The Company's current expectation is that future payment or performance related to the non-performance of others is considered remote.

The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States and a committed facility in Europe. Under the terms of the Programs, the Company continues to service the receivables from the customers, but retains no interest in the receivables, and remits payment to the financial institutions. The Company also has access to accounts receivable discounting facilities, under which receivables are transferred with limited recourse. The Company's maximum guaranteed liability for the accounts receivable facilities is $5 million at June 30, 2025 ($239 million at December 31, 2024). The Company expects receivable collections and remittances to occur within the next six months.

TDCC has entered into guarantee agreements related to Sadara, a nonconsolidated affiliate. Sadara reached an agreement with its lenders to re-profile its outstanding project financing debt in the first quarter of 2021. In conjunction with the debt re-profiling, TDCC entered into a guarantee of up to approximately $1.3 billion of Sadara's debt, proportionate to the Company's 35 percent ownership interest. The debt re-profiling also includes a grace period until June 2026, during which Sadara is obligated to make interest-only payments which are guaranteed by TDCC in proportion to the Company's 35 percent ownership interest. The Company does not expect to be required to perform under the guarantees. As part of the debt re-profiling, Sadara established a $500 million revolving credit facility guaranteed by Dow, which would be used to fund Dow's pro-rata share of any potential shortfall during the grace period.

**Asset Retirement Obligations**

Asset retirement obligations are recorded as incurred and reasonably estimable, including obligations for which the timing and/or method of settlement are conditional on a future event that may or may not be within the control of the Company. The retirement of assets may involve such efforts as remediation and treatment of asbestos, contractually required demolition, and other related activities, depending on the nature and location of the assets; and retirement obligations are typically realized only upon demolition of those facilities. As a result of the asset shutdowns included in the restructuring activities discussed in Note 5, the Company accrued additional asset retirement obligations of $111 million in the second quarter of 2025. At June 30, 2025, the aggregate carrying amount of the Company's asset retirement obligations was $300 million ($174 million at December 31, 2024), which was included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**NOTE 15 – LEASES**

For additional information on the Company's leases, see Note 16 to the Consolidated Financial Statements included in the 2024 10-K.

The components of lease cost for operating and finance leases for the three and six months ended June 30, 2025 and 2024 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Lease Cost** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| Operating lease cost | $109 | $110 | $215 | $217 |
| Finance lease cost |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of right-of-use assets - finance | 32 | 28 | 64 | 55 |
| &nbsp;&nbsp;&nbsp;Interest on lease liabilities - finance | 12 | 12 | 24 | 22 |
| Total finance lease cost | 44 | 40 | 88 | 77 |
| Short-term lease cost | 87 | 88 | 167 | 162 |
| Variable lease cost | 283 | 265 | 538 | 523 |
| Sublease income | (1) | (3) | (3) | (5) |
| Total lease cost | $522 | $500 | $1005 | $974 |

---

The following table provides supplemental cash flow and other information related to leases:

---

| | | |
|:---|:---|:---|
| **Other Lease Information** | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* |
| Cash paid for amounts included in the measurement of lease liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Operating cash flows for operating leases | $222 | $223 |
| &nbsp;&nbsp;&nbsp;Operating cash flows for finance leases | $24 | $22 |
| &nbsp;&nbsp;&nbsp;Financing cash flows for finance leases | $54 | $61 |
| Right-of-use assets obtained in exchange for lease obligations: |  |  |
| &nbsp;&nbsp;&nbsp;Operating leases | $108 | $119 |
| &nbsp;&nbsp;&nbsp;Finance leases | $165 | $168 |

---

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**NOTE 16 – ACCUMULATED OTHER COMPREHENSIVE LOSS**

The changes in each component of accumulated other comprehensive loss ("AOCL") for the three and six months ended June 30, 2025 and 2024 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Accumulated Other Comprehensive Loss** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| **Unrealized Gains (Losses) on Investments** |  |  |  |  |
| Beginning balance | $(211) | $(259) | $(243) | $(253) |
| &nbsp;&nbsp;&nbsp;Unrealized gains (losses) on investments | (25) | 65 | 15 | 80 |
| &nbsp;&nbsp;&nbsp;Tax (expense) benefit | 2 | (2) | (5) | (20) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains (losses) on investments | (23) | 63 | 10 | 60 |
| &nbsp;&nbsp;&nbsp;&nbsp;(Gains) losses reclassified from AOCL to net income (loss) <sup>1</sup> | 1 | (3) |  | (7) |
| &nbsp;&nbsp;&nbsp;Tax expense (benefit) <sup>2</sup> |  | 1 |  | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net (gains) losses reclassified from AOCL to net income (loss) | 1 | (2) |  | (5) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of tax | (22) | 61 | 10 | 55 |
| Ending balance | $(233) | $(198) | $(233) | $(198) |
| **Cumulative Translation Adjustments** |  |  |  |  |
| Beginning balance | $(1941) | $(2013) | $(2063) | $(1891) |
| &nbsp;&nbsp;&nbsp;Gains (losses) on foreign currency translation | 129 | (39) | 255 | (155) |
| &nbsp;&nbsp;&nbsp;Tax (expense) benefit | 12 |  | 15 | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net gains (losses) on foreign currency translation | 141 | (39) | 270 | (158) |
| &nbsp;&nbsp;&nbsp;&nbsp;(Gains) losses reclassified from AOCL to net income (loss) <sup>3</sup> | (12) | (4) | (19) | (7) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of tax | 129 | (43) | 251 | (165) |
| Ending balance | $(1812) | $(2056) | $(1812) | $(2056) |
| **Pension and Other Postretirement Benefit Plans** |  |  |  |  |
| Beginning balance | $(5700) | $(5469) | $(5720) | $(5486) |
| &nbsp;&nbsp;&nbsp;Gains (losses) arising during the period | 1 | 1 | 1 |  |
| &nbsp;&nbsp;&nbsp;Amortization of net loss and prior service credits reclassified from AOCL to net income (loss) <sup>4</sup> | 26 | 21 | 52 | 43 |
| &nbsp;&nbsp;&nbsp;Tax expense (benefit) <sup>2</sup> | (6) | (5) | (12) | (9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net loss and prior service credits reclassified from AOCL to net income (loss) | 20 | 16 | 40 | 34 |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of tax | 21 | 17 | 41 | 34 |
| Ending balance | $(5679) | $(5452) | $(5679) | $(5452) |
| **Derivative Instruments** |  |  |  |  |
| Beginning balance | $(104) | $(73) | $(84) | $(51) |
| &nbsp;&nbsp;&nbsp;Gains (losses) on derivative instruments | 6 | (13) | (9) | (46) |
| &nbsp;&nbsp;&nbsp;Tax (expense) benefit | (4) | 8 | (6) | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net gains (losses) on derivative instruments | 2 | (5) | (15) | (35) |
| &nbsp;&nbsp;&nbsp;&nbsp;(Gains) losses reclassified from AOCL to net income (loss) <sup>5</sup> | 1 | (1) | (3) | 9 |
| &nbsp;&nbsp;&nbsp;Tax expense (benefit) <sup>2</sup> | (1) |  |  | (2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net (gains) losses reclassified from AOCL to net income (loss) |  | (1) | (3) | 7 |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of tax | 2 | (6) | (18) | (28) |
| Ending balance | $(102) | $(79) | $(102) | $(79) |
| Total AOCL ending balance | $(7826) | $(7785) | $(7826) | $(7785) |

---

1. Reclassified to "Net sales" and "Sundry income (expense) - net."

2. Reclassified to "Provision for income taxes."

3. Reclassified to "Sundry income (expense) - net."

4. These AOCL components are included in the computation of net periodic benefit cost (credit) of the Company's defined benefit pension and other postretirement benefit plans. See Note 18 for additional information.

5. Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**NOTE 17 – NONCONTROLLING INTERESTS**

Ownership interests in the Company's subsidiaries held by parties other than the Company are presented separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the face of the consolidated statements of income.

On May 1, 2025, TDCC sold 40 percent of the membership interests of its wholly owned subsidiary, Diamond Infrastructure Solutions, a dedicated infrastructure company, to InfraPark Holdings, LLC ("InfraPark"), a subsidiary of a fund managed by Macquarie Asset Management, a global infrastructure and energy asset manager, in exchange for cash proceeds of approximately $2.4 billion, included in "Proceeds from sale of noncontrolling interests" in the consolidated statements of cash flows. Under the terms of the sale and purchase agreement, InfraPark has the option to purchase up to an additional 9 percent of Diamond Infrastructure Solutions' membership interests within six months of the closing date of the sale in exchange for additional cash proceeds of up to $600 million. Diamond Infrastructure Solutions and its subsidiaries own and operate certain non-product producing energy, environmental, pipeline and other related infrastructure assets located at five of the Company's manufacturing sites on the U.S. Gulf Coast and provides infrastructure services to Dow manufacturing assets and other third-party tenants at these locations. InfraPark's ownership is accounted for as a noncontrolling interest in Diamond Infrastructure Solutions. The transaction resulted in an increase in "Additional paid-in capital" of $1,540 million, recorded in the consolidated balance sheets and the consolidated statements of equity, and an increase in "Noncontrolling interests" of $834 million, recorded in the consolidated balance sheets.

The following table summarizes the activity for equity attributable to noncontrolling interests for the three and six months ended June 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Noncontrolling Interests** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| <br>In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| Balance at beginning of period | $507 | $492 | $496 | $501 |
| Net income attributable to noncontrolling interests | 34 | 19 | 51 | 41 |
| Distributions to noncontrolling interests <sup>1</sup> | (26) | (25) | (48) | (39) |
| Cumulative translation adjustments | 12 | (4) | 28 | (20) |
| Sale of noncontrolling interests | 834 |  | 834 |  |
| Other |  |  |  | (1) |
| Balance at end of period | $1361 | $482 | $1361 | $482 |

---

1. Includes dividends paid to a joint venture of $8 million for the three and six months ended June 30, 2025 ($8 million for the three and six months ended June 30, 2024) which were reclassified to "Equity in earnings of nonconsolidated affiliates" in the consolidated statements of income.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**NOTE 18 – PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS**

A summary of the Company's pension and other postretirement benefit plans can be found in Note 19 to the Consolidated Financial Statements included in the 2024 10-K. The following table provides the components of the Company's net periodic benefit cost (credit) for all significant plans:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Net Periodic Benefit Cost (Credit) for All Significant Plans** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| **Defined Benefit Pension Plans** |  |  |  |  |
| &nbsp;&nbsp;Service cost | $11 | $14 | $21 | $28 |
| &nbsp;&nbsp;Interest cost | 249 | 250 | 495 | 502 |
| &nbsp;&nbsp;Expected return on plan assets | (322) | (343) | (641) | (689) |
| &nbsp;&nbsp;Amortization of prior service credit | (3) | (4) | (6) | (7) |
| &nbsp;&nbsp;Amortization of net loss | 41 | 36 | 81 | 71 |
| &nbsp;&nbsp;Net periodic benefit credit | $(24) | $(47) | $(50) | $(95) |
| **Other Postretirement Benefit Plans** |  |  |  |  |
| &nbsp;&nbsp;Service cost | $1 | $1 | $2 | $2 |
| &nbsp;&nbsp;Interest cost | 11 | 11 | 20 | 22 |
| &nbsp;&nbsp;Amortization of net gain | (12) | (11) | (23) | (21) |
| &nbsp;&nbsp;Net periodic benefit cost (credit) | $— | $1 | $(1) | $3 |

---

Net periodic benefit cost (credit), other than the service cost component, is included in "Sundry income (expense) - net" in the consolidated statements of income.

**NOTE 19 – STOCK-BASED COMPENSATION**

A summary of the Company's stock-based compensation plans can be found in Note 20 to the Consolidated Financial Statements included in the 2024 10-K.

**Stock Incentive Plan**

The Company grants stock-based compensation to employees and non-employee directors under the 2019 Stock Incentive Plan, as amended. Most of the Company's stock-based compensation awards are granted in the first quarter of each year.

In the first quarter of 2025, Dow Inc. granted the following stock-based compensation awards to employees:

• 1.8 million stock options with a weighted-average exercise price of $38.34 per share and a weighted-average fair value of $8.27 per share;

• 3.0 million restricted stock units with a weighted-average fair value of $38.34 per share; and

• 2.1 million performance stock units with a weighted-average fair value of $38.46 per share.

There was minimal grant activity in the second quarter of 2025.

**Employee Stock Purchase Plan**

The Dow Inc. 2021 Employee Stock Purchase Plan (the "2021 ESPP") was adopted by the Board on February 11, 2021, and approved by stockholders at the Company's annual meeting on April 15, 2021. Under the 2025 annual offering of the 2021 ESPP, most employees will be eligible to purchase shares of common stock of Dow Inc. valued at up to 10 percent of their annual total base salary or wages. The number of shares purchased is determined using the amount contributed by the employee divided by the plan price. The plan price of the stock is equal to 85 percent of the fair market value (closing price) of the common stock at March 31, 2025 (beginning) or October 3, 2025 (ending) of the offering period, whichever is lower.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

In the first quarter of 2025, employees subscribed to the right to purchase approximately 3.2 million shares under the 2021 ESPP. In the second quarter of 2025, due to the change in the Company's stock price, employees now have the right to purchase approximately 3.9 million shares. The plan price is fixed upon the close of the offering period and will be determined in the fourth quarter of 2025. The shares will be delivered to employees in the fourth quarter of 2025.

**NOTE 20 – FINANCIAL INSTRUMENTS**

A summary of the Company's financial instruments, risk management policies, derivative instruments and hedging activities can be found in Note 21 to the Consolidated Financial Statements included in the 2024 10-K.

Refer to Note 21 for a summary of the fair value of financial instruments at June 30, 2025 and December 31, 2024.

**Debt Securities**

The Company's investments in debt securities are primarily classified as available-for-sale. The following table provides investing results from available-for-sale securities for the six months ended June 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| **Investing Results** | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* |
| Proceeds from sales of available-for-sale securities | $220 | $1291 |
| Gross realized gains | $5 | $19 |
| Gross realized losses | $(5) | $(12) |

---

The following table summarizes contractual maturities of the Company's investments in debt securities:

---

| | | |
|:---|:---|:---|
| **Contractual Maturities of Debt Securities at Jun 30, 2025** | *Cost* | *Fair Value* |
| In millions | *Cost* | *Fair Value* |
| Within one year | $120 | $113 |
| One to five years | 1151 | 1058 |
| Six to ten years | 407 | 403 |
| After ten years | 544 | 447 |
| Total | $2222 | $2021 |

---

**Equity Securities**

There were no material adjustments to the carrying value of the not readily determinable investments for impairment or observable price changes for the three and six months ended June 30, 2025. There was $1 million of net unrealized gains recognized in earnings on equity securities for the three months ended June 30, 2025 (no unrealized gains or losses for the three months ended June 30, 2024). There was $2 million of net unrealized losses recognized in earnings on equity securities for the six months ended June 30, 2025 (no unrealized gains or losses for the six months ended June 30, 2024).

---

| | | |
|:---|:---|:---|
| **Investments in Equity Securities** | *Jun 30, 2025* | *Dec 31, 2024* |
| In millions | *Jun 30, 2025* | *Dec 31, 2024* |
| Readily determinable fair value | $12 | $14 |
| Not readily determinable fair value | $145 | $153 |

---

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Derivative Instruments**

The notional amounts of the Company's derivative instruments at June 30, 2025 and December 31, 2024 were as follows:

---

| | | |
|:---|:---|:---|
| **Notional Amounts** <sup>1</sup> | *Jun 30, 2025* | *Dec 31, 2024* |
| In millions | *Jun 30, 2025* | *Dec 31, 2024* |
| Derivatives designated as hedging instruments: |  |  |
| &nbsp;&nbsp;&nbsp;Interest rate contracts | $2572 | $1870 |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts | $6148 | $3144 |
| Derivatives not designated as hedging instruments: |  |  |
| &nbsp;&nbsp;&nbsp;Interest rate contracts | $884 | $14 |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts | $20332 | $9244 |

---

1. Notional amounts represent the absolute value of open derivative positions at the end of the period. Multi-leg option positions are reflected at the maximum notional position at expiration.

The notional amounts of the Company's commodity derivatives at June 30, 2025 and December 31, 2024 were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Commodity Notionals** <sup>1</sup> | *Jun 30, 2025* | *Dec 31, 2024* | *Notional Volume Unit* |
| Derivatives designated as hedging instruments: |  |  |  |
| &nbsp;&nbsp;&nbsp;Hydrocarbon derivatives | 4.7 | 3.2 | million barrels of oil equivalent |
| Derivatives not designated as hedging instruments: |  |  |  |
| &nbsp;&nbsp;&nbsp;Hydrocarbon derivatives | 0.8 | 1.1 | million barrels of oil equivalent |

---

1. Notional amounts represent the net volume of open derivative positions outstanding at the end of the period.

---

| | |
|:---|:---|
| **Maximum Maturity Dates of Derivatives Designated as Hedging Instruments** | *Year* |
| Interest rate contracts | 2027 |
| Foreign currency contracts | 2026 |
| Commodity contracts | 2028 |

---

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

The following table provides the fair value and balance sheet classification of derivative instruments at June 30, 2025 and December 31, 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Fair Value of Derivative Instruments** | *Jun 30, 2025* | *Jun 30, 2025* | *Jun 30, 2025* | *Dec 31, 2024* | *Dec 31, 2024* | *Dec 31, 2024* |
| In millions | *Gross* | *Counterparty and Cash Collateral Netting* <sup>1</sup> | *Net* <sup>2</sup> | *Gross* | *Counterparty and Cash Collateral Netting* <sup>1</sup> | *Net* <sup>2</sup> |
| **Asset derivatives** |  |  |  |  |  |  |
| Derivatives designated as hedging instruments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest rate contracts <sup>3</sup> | $99 | $(68) | $31 | $20 | $(20) | $— |
| &nbsp;&nbsp;&nbsp;Interest rate contracts <sup>4</sup> | 20 | (16) | 4 |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts <sup>3</sup> | 57 | (56) | 1 | 33 | (15) | 18 |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts <sup>4</sup> | 1 | (1) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Commodity contracts <sup>3</sup> | 136 | (110) | 26 | 25 | (14) | 11 |
| &nbsp;&nbsp;&nbsp;Commodity contracts <sup>4</sup> | 108 | (95) | 13 | 46 | (36) | 10 |
| &nbsp;&nbsp;&nbsp;Total | $421 | $(346) | $75 | $124 | $(85) | $39 |
| Derivatives not designated as hedging instruments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest rate contracts <sup>3</sup> | $5 | $(4) | $1 | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;Interest rate contracts <sup>4</sup> | 1 | (1) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts <sup>3</sup> | 93 | (83) | 10 | 74 | (16) | 58 |
| &nbsp;&nbsp;&nbsp;Commodity contracts <sup>3</sup> | 31 | (14) | 17 | 16 | (1) | 15 |
| &nbsp;&nbsp;&nbsp;Commodity contracts <sup>4</sup> | 5 | (4) | 1 | 4 | (3) | 1 |
| &nbsp;&nbsp;&nbsp;Total | $135 | $(106) | $29 | $94 | $(20) | $74 |
| Total asset derivatives | $556 | $(452) | $104 | $218 | $(105) | $113 |
| **Liability derivatives** |  |  |  |  |  |  |
| Derivatives designated as hedging instruments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest rate contracts <sup>5</sup> | $70 | $(68) | $2 | $46 | $(20) | $26 |
| &nbsp;&nbsp;&nbsp;Interest rate contracts <sup>6</sup> | 16 | (16) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts <sup>5</sup> | 155 | (56) | 99 | 75 | (15) | 60 |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts <sup>6</sup> | 1 | (1) |  | 40 |  | 40 |
| &nbsp;&nbsp;&nbsp;Commodity contracts <sup>5</sup> | 139 | (113) | 26 | 16 | (14) | 2 |
| &nbsp;&nbsp;&nbsp;Commodity contracts <sup>6</sup> | 103 | (96) | 7 | 37 | (36) | 1 |
| &nbsp;&nbsp;&nbsp;Total | $484 | $(350) | $134 | $214 | $(85) | $129 |
| Derivatives not designated as hedging instruments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest rate contracts <sup>5</sup> | $4 | $(4) | $— | $1 | $— | $1 |
| &nbsp;&nbsp;&nbsp;Interest rate contracts <sup>6</sup> | 1 | (1) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts <sup>5</sup> | 183 | (83) | 100 | 27 | (16) | 11 |
| &nbsp;&nbsp;&nbsp;Commodity contracts <sup>5</sup> | 33 | (18) | 15 | 8 | (1) | 7 |
| &nbsp;&nbsp;&nbsp;Commodity contracts <sup>6</sup> | 5 | (4) | 1 | 4 | (3) | 1 |
| &nbsp;&nbsp;&nbsp;Total | $226 | $(110) | $116 | $40 | $(20) | $20 |
| Total liability derivatives | $710 | $(460) | $250 | $254 | $(105) | $149 |

---

1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

2. Represents the net amounts included in the consolidated balance sheets.

3. Included in "Other current assets" in the consolidated balance sheets.

4. Included in "Deferred charges and other assets" in the consolidated balance sheets.

5. Included in "Accrued and other current liabilities" in the consolidated balance sheets.

6. Included in "Other noncurrent obligations" in the consolidated balance sheets.

Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

collateral of $15 million at June 30, 2025 ($16 million at December 31, 2024). No cash collateral was posted by counterparties with the Company at June 30, 2025 and December 31, 2024.

The following table summarizes the gain (loss) of derivative instruments in the consolidated statements of income and comprehensive income for the three and six months ended June 30, 2025 and 2024:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Effect of Derivative Instruments** | *Gain (loss) recognized in OCI* <sup>1</sup> | *Gain (loss) recognized in OCI* <sup>1</sup> | *Gain (loss) recognized in OCI* <sup>1</sup> | *Gain (loss) recognized in OCI* <sup>1</sup> | *Gain (loss) recognized in income* <sup>2</sup> | *Gain (loss) recognized in income* <sup>2</sup> | *Gain (loss) recognized in income* <sup>2</sup> | *Gain (loss) recognized in income* <sup>2</sup> |
|  | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| *Derivatives designated as hedging instruments:* |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Fair value hedges: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate contracts <sup>3, 4</sup> | $— | $— | $— | $— | $13 | $(23) | $33 | $(23) |
| &nbsp;&nbsp;&nbsp;&nbsp;Excluded components <sup>3, 5</sup> | 4 | (4) | (1) | (42) |  |  |  |  |
| &nbsp;&nbsp;Cash flow hedges: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate contracts <sup>3</sup> | (1) |  |  | 1 |  | (7) | (1) | (9) |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency contracts <sup>6</sup> | 36 | (8) | 30 | (21) | 3 | 4 | 5 | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency contracts <sup>7</sup> | (15) |  | (15) |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commodity contracts <sup>6</sup> | (17) | 7 | (11) | 22 | (5) | 7 | (1) | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Excluded components <sup>5, 6</sup> |  |  |  | (6) | (2) | (3) | (3) | (4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Excluded components <sup>7</sup> | 7 |  | 7 |  | 3 |  | 3 |  |
| &nbsp;&nbsp;Net foreign investment hedges: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency contracts | (55) | 6 | (82) | 8 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Excluded components <sup>5, 7</sup> | 4 | 4 | 31 | 10 | 12 | 4 | 19 | 7 |
| Total derivatives designated as hedging instruments | $(37) | $5 | $(41) | $(28) | $24 | $(18) | $55 | $(25) |
| *Derivatives not designated as hedging instruments:* |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Interest rate contracts <sup>3</sup> | $— | $— | $— | $— | $2 | $1 | $2 | $1 |
| &nbsp;&nbsp;Foreign currency contracts <sup>7</sup> |  |  |  |  | (156) | 29 | (212) | 60 |
| &nbsp;&nbsp;Commodity contracts <sup>6</sup> |  |  |  |  | (12) | (6) | (17) | 2 |
| &nbsp;&nbsp;Total return swap <sup>6</sup> |  |  |  |  | 35 | 4 | 24 | 26 |
| Total derivatives not designated as hedging instruments | $— | $— | $— | $— | $(131) | $28 | $(203) | $89 |
| Total derivatives | $(37) | $5 | $(41) | $(28) | $(107) | $10 | $(148) | $64 |

---

1. OCI is defined as other comprehensive income (loss).

2. Pretax amounts.

3. Included in "Interest expense and amortization of debt discount" in the consolidated statements of income.

4. Gain (loss) recognized in income of derivatives is offset by gain (loss) recognized in income of the hedged item.

5. The excluded components are related to the time value of the derivatives designated as hedges.

6. Included in "Cost of sales" in the consolidated statements of income.

7. Included in "Sundry income (expense) - net" in the consolidated statements of income.

The following table provides the net after-tax gain (loss) expected to be reclassified from AOCL to income within the next 12 months:

---

| | |
|:---|:---|
| **Expected Reclassifications from AOCL within the next 12 months** | *Jun 30, 2025* |
| In millions | *Jun 30, 2025* |
| Cash flow hedges: |  |
| &nbsp;&nbsp;&nbsp;Interest rate contracts | $(3) |
| &nbsp;&nbsp;&nbsp;Commodity contracts | $(3) |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts | $(21) |
| &nbsp;&nbsp;&nbsp;Excluded components | $2 |
| Net foreign investment hedges: |  |
| &nbsp;&nbsp;&nbsp;Excluded components | $23 |

---

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**NOTE 21 – FAIR VALUE MEASUREMENTS**

A summary of the Company's recurring and nonrecurring fair value measurements can be found in Note 22 to the Consolidated Financial Statements included in the 2024 10-K.

**Fair Value Measurements on a Recurring Basis**

The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Fair Value Measurements on a Recurring Basis** | **Fair Value Measurements on a Recurring Basis** | *Jun 30, 2025* | *Jun 30, 2025* | *Jun 30, 2025* | *Jun 30, 2025* | *Dec 31, 2024* | *Dec 31, 2024* | *Dec 31, 2024* | *Dec 31, 2024* |
| In millions | *Fair Value Level* | *Cost* | *Gain* | *Loss* | *Fair Value* | *Cost* | *Gain* | *Loss* | *Fair Value* |
| Assets at fair value: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Cash equivalents: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Held-to-maturity securities <sup>1</sup> | Level 2 | $234 | $— | $— | $234 | $96 | $— | $— | $96 |
| &nbsp;&nbsp;&nbsp;&nbsp;Money market funds | Level 2 | 841 |  |  | 841 | 1164 |  |  | 1164 |
| &nbsp;&nbsp;Marketable securities <sup>2</sup> | Level 2 | 393 |  | (87) | 306 | 453 |  | (70) | 383 |
| &nbsp;&nbsp;Other investments: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt securities: <sup>3</sup> |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Government debt <sup>4</sup> | Level 2 | 1132 | 14 | (106) | 1040 | 1103 | 13 | (123) | 993 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate bonds | Level 1 | 17 |  | (1) | 16 | 18 |  | (1) | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate bonds | Level 2 | 873 | 9 | (69) | 813 | 954 | 6 | (88) | 872 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate bonds | Level 3 | 200 |  | (48) | 152 | 200 |  | (49) | 151 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity securities <sup>3, 5</sup> | Level 1 | 4 | 8 |  | 12 | 4 | 10 |  | 14 |
| &nbsp;&nbsp;Derivatives relating to: <sup>6</sup> |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest rates | Level 2 |  | 125 |  | 125 |  | 20 |  | 20 |
| &nbsp;&nbsp;&nbsp;Foreign currency | Level 2 |  | 151 |  | 151 |  | 107 |  | 107 |
| &nbsp;&nbsp;&nbsp;Commodities | Level 1 |  | 15 |  | 15 |  | 4 |  | 4 |
| &nbsp;&nbsp;&nbsp;Commodities | Level 2 |  | 265 |  | 265 |  | 87 |  | 87 |
| Total assets at fair value |  |  |  |  | $3970 |  |  |  | $3908 |
| Liabilities at fair value: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Long-term debt including debt due within one year <sup>7</sup> | Level 2 | $(16648) | $1543 | $(435) | $(15540) | $(16208) | $1487 | $(484) | $(15205) |
| &nbsp;&nbsp;Guarantee liability <sup>8</sup> | Level 3 |  |  |  | (144) |  |  |  | (155) |
| &nbsp;&nbsp;Derivatives relating to: <sup>6</sup> |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest rates | Level 2 |  |  | (91) | (91) |  |  | (47) | (47) |
| &nbsp;&nbsp;&nbsp;Foreign currency | Level 2 |  |  | (339) | (339) |  |  | (142) | (142) |
| &nbsp;&nbsp;&nbsp;Commodities | Level 1 |  |  | (17) | (17) |  |  | (1) | (1) |
| &nbsp;&nbsp;&nbsp;Commodities | Level 2 |  |  | (263) | (263) |  |  | (64) | (64) |
| Total liabilities at fair value |  |  |  |  | $(16394) |  |  |  | $(15614) |

---

1. The Company's held-to-maturity securities primarily relate to treasury bills and time deposits. At June 30, 2025, $216 million is included in "Cash and cash equivalents" ($96 million at December 31, 2024) and $18 million is included in "Other current assets" (zero at December 31, 2024) in the consolidated balance sheets.

2. The Company's investments in marketable securities are included in "Other current assets" in the consolidated balance sheets.

3. The Company's investments in debt securities, which are primarily available-for-sale, and equity securities are included in "Other investments" in the consolidated balance sheets.

4. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities' obligations.

5. Equity securities with a readily determinable fair value.

6. See Note 20 for classification of derivatives in the consolidated balance sheets.

7. Cost includes fair value hedge adjustment gains of $43 million at June 30, 2025 and $9 million at December 31, 2024 on $5,538 million of debt at June 30, 2025 and $5,129 million at December 31, 2024.

8. Estimated liability for TDCC's guarantee of Sadara's debt which is included in "Other noncurrent obligations" in the consolidated balance sheets.

Cost approximates fair value for all other financial instruments.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

For equity securities calculated at net asset value per share (or its equivalent), the Company had $83 million in private market securities and $14 million in real estate at June 30, 2025 ($90 million in private market securities and $15 million in real estate at December 31, 2024). There are no redemption restrictions and the unfunded commitments on these investments were $79 million at June 30, 2025 and $81 million at December 31, 2024.

For assets classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The level 3 asset values represent the fair value of an investment in a corporate bond, accounted for as a debt security.

For liabilities classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Company's accrued liability related to the guarantee of Sadara's debt is in proportion to the Company's 35 percent ownership interest in Sadara. The estimated fair value of the guarantee was calculated using a "with" and "without" method. The fair value of the debt was calculated "with" the guarantee less the fair value of the debt "without" the guarantee. The "with" and "without" values were calculated using a discounted cash flow method based on contractual cash flows as well as projected prepayments made on the debt by Sadara.

**Fair Value Measurements on a Nonrecurring Basis**

*2025 Restructuring Program*

In the second quarter of 2025, the Company recorded a charge for asset write-downs and write-offs, including the write-down of certain manufacturing facilities, corporate assets, leased, non-manufacturing facilities and other miscellaneous assets. The manufacturing facilities, corporate assets and certain leased, non-manufacturing facilities and other miscellaneous assets associated with this plan were written down to zero. In addition, impairments of certain leased, non-manufacturing facilities and other miscellaneous assets, which were classified as Level 3 measurements, resulted in a write-down of right-of-use assets to a fair value of $110 million using unobservable inputs. The Company recorded impairment charges of $334 million for asset write-downs and write-offs, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics ($81 million), Industrial Intermediates & Infrastructure ($63 million), Performance Materials & Coatings ($147 million) and Corporate ($43 million).

*2023 Restructuring Program*

In the first quarter of 2025, the Company recorded impairment charges of $5 million for asset write-downs and write-offs, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure.

**NOTE 22 – VARIABLE INTEREST ENTITIES**

A summary of the Company's variable interest entities ("VIEs") not discussed below can be found in Note 23 to the Consolidated Financial Statements included in the 2024 10-K.

**Assets and Liabilities of Consolidated VIEs**

The Company's consolidated financial statements include the assets, liabilities and results of operations of VIEs for which the Company is the primary beneficiary. The other equity holders' interests are included in "Net income attributable to noncontrolling interests" in the consolidated statements of income and "Noncontrolling interests" in the consolidated balance sheets.

*Infrastructure Entity*

The Company has variable interests in Diamond Infrastructure Solutions, an entity that owns and operates infrastructure assets at certain Dow locations on the U.S Gulf Coast as discussed in Note 17. The Company's variable interests relate to its membership interest and the service contracts between Diamond Infrastructure Solutions and Dow, under which a majority of the infrastructure services are provided to Dow using pass-through and cost-plus pricing. Diamond Infrastructure Solutions became a variable interest entity effective with the noncontrolling interest transaction on May 1, 2025. Dow is deemed the primary beneficiary as a result of decision rights held as the majority member.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

The following table summarizes the carrying amounts of Diamond Infrastructure Solutions' assets and liabilities included in the Company's consolidated balance sheets at June 30, 2025. Amounts presented are adjusted for intercompany eliminations.

---

| | |
|:---|:---|
| **Assets and Liabilities of Diamond Infrastructure Solutions** | *Jun 30, 2025* |
| In millions | *Jun 30, 2025* |
| Other current assets | $163 |
| Net property | 2259 |
| Other noncurrent assets | 196 |
| Total assets <sup>1</sup> | $2618 |
| Current liabilities | $338 |
| Long-term debt | 176 |
| Other noncurrent obligations | 316 |
| Total liabilities <sup>2</sup> | $830 |

---

1. All assets were restricted at June 30, 2025.

2. All liabilities were nonrecourse at June 30, 2025.

In addition, the Company holds a variable interest and is the primary beneficiary of other joint ventures and entities. The following table summarizes the carrying amounts of other entities' assets and liabilities included in the Company's consolidated balance sheets at June 30, 2025 and December 31, 2024:

---

| | | |
|:---|:---|:---|
| **Assets and Liabilities of Other Consolidated VIEs** | *Jun 30, 2025* | *Dec 31, 2024* |
| In millions | *Jun 30, 2025* | *Dec 31, 2024* |
| Cash and cash equivalents | $9 | $22 |
| Other current assets | 275 | 250 |
| Net property | 121 | 122 |
| Other noncurrent assets | 16 | 15 |
| Total assets <sup>1</sup> | $421 | $409 |
| Current liabilities | $27 | $24 |
| Other noncurrent obligations | 13 | 13 |
| Total liabilities <sup>2</sup> | $40 | $37 |

---

1. Restricted assets totaled $183 million and $192 million at June 30, 2025 and December 31, 2024, respectively.

2. All liabilities were nonrecourse at June 30, 2025 and December 31, 2024.

Amounts presented in the consolidated balance sheets and the table above as restricted assets or nonrecourse obligations relating to consolidated VIEs at June 30, 2025 and December 31, 2024 are adjusted for intercompany eliminations.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**NOTE 23 – SEGMENTS AND GEOGRAPHIC REGIONS**

Sales to external customers, which are attributed to geographic regions based on customer location, were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Sales to External Customers by Geographic Region** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| United States | $3725 | $3909 | $7671 | $7738 |
| EMEAI | 3272 | 3572 | 6546 | 7056 |
| Rest of World | 3107 | 3434 | 6318 | 6886 |
| Total | $10104 | $10915 | $20535 | $21680 |

---

Long-lived assets, which are attributed to geographic regions based on asset location, were as follows:

---

| | | |
|:---|:---|:---|
| **Long-Lived Assets by Geographic Region** | *Jun 30, 2025* | *Dec 31, 2024* |
| In millions | *Jun 30, 2025* | *Dec 31, 2024* |
| United States | $15050 | $15216 |
| EMEAI | 2785 | 2726 |
| Rest of World | 4641 | 4062 |
| Total | $22476 | $22004 |

---

Dow's measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the chief executive officer, chief operating officer, chief financial officer, general counsel and corporate secretary, and senior vice president of corporate development, together the "executive committee" and CODM, assesses performance and allocates resources. The CODM compares quarterly results to both the year-ago and sequential periods to assess performance and allocate resources to each segment. The Company defines Operating EBIT as earnings (i.e., "Income (loss) before income taxes") before interest, excluding the impact of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Segment Operating EBIT** <sup>1</sup> | *Pack. & Spec. Plastics* | *Ind. Interm. & Infrast.* | *Perf. Materials & Coatings* | *Operating Segment Total* |
| In millions | *Pack. & Spec. Plastics* | *Ind. Interm. & Infrast.* | *Perf. Materials & Coatings* | *Operating Segment Total* |
| *Three months ended Jun 30, 2025* |  |  |  |  |
| Net sales | $5025 | $2786 | $2129 | $9940 |
| Cost of sales | 4728 | 2832 | 1814 | 9374 |
| SARD <sup>2</sup> | 221 | 116 | 147 | 484 |
| Equity in earnings (losses) of nonconsolidated affiliates | 7 | (39) | 1 | (31) |
| Other segment income (expense) items <sup>3</sup> | (12) | 16 | (17) | (13) |
| Segment Operating EBIT <sup>4</sup> | $71 | $(185) | $152 | $38 |
| *Three months ended Jun 30, 2024* |  |  |  |  |
| Net sales | $5515 | $2951 | $2243 | $10709 |
| Cost of sales | 4616 | 2803 | 1915 | 9334 |
| SARD <sup>2</sup> | 253 | 127 | 157 | 537 |
| Equity in earnings (losses) of nonconsolidated affiliates | 55 | (31) | 2 | 26 |
| Other segment income (expense) items <sup>3</sup> | 2 | 17 | (27) | (8) |
| Segment Operating EBIT <sup>4</sup> | $703 | $7 | $146 | $856 |
| *Six months ended Jun 30, 2025* |  |  |  |  |
| Net sales | $10335 | $5641 | $4200 | $20176 |
| Cost of sales | 9493 | 5654 | 3659 | 18806 |
| SARD <sup>2</sup> | 461 | 243 | 298 | 1002 |
| Equity in earnings (losses) of nonconsolidated affiliates | 46 | (97) | 1 | (50) |
| Other segment income (expense) items <sup>3</sup> | (14) | 40 | (43) | (17) |
| Segment Operating EBIT <sup>4</sup> | $413 | $(313) | $201 | $301 |
| *Six months ended Jun 30, 2024* |  |  |  |  |
| Net sales | $10945 | $5959 | $4395 | $21299 |
| Cost of sales | 9213 | 5579 | 3809 | 18601 |
| SARD <sup>2</sup> | 508 | 263 | 354 | 1125 |
| Equity in earnings (losses) of nonconsolidated affiliates | 80 | (46) | 8 | 42 |
| Other segment income (expense) items <sup>3</sup> | 4 | 23 | (53) | (26) |
| Segment Operating EBIT <sup>4</sup> | $1308 | $94 | $187 | $1589 |

---

1. Significant expense categories are presented on an operating basis, net of the impact of significant items.

2. SARD includes selling, general and administrative and research and development expenses.

3. Other segment items includes amortization of intangibles and sundry income (expense) - net.

4. Segment Operating EBIT for TDCC for the three and six months ended June 30, 2025 and 2024 is substantially the same as that of Dow Inc. and therefore is not disclosed separately in the table above. A reconciliation of "Segment Operating EBIT" to "Income (loss) before income taxes" is provided in the following table.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Reconciliation of "Segment Operating EBIT" to "Income (Loss) Before Income Taxes"** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| Segment Operating EBIT | $38 | $856 | $301 | $1589 |
| &nbsp;&nbsp;+ Corporate Operating EBIT | (59) | (37) | (92) | (96) |
| &nbsp;&nbsp;+ Interest income | 39 | 42 | 67 | 107 |
| &nbsp;&nbsp;- Interest expense and amortization of debt discount | 209 | 197 | 425 | 396 |
| &nbsp;&nbsp;+ Significant items | (468) | (56) | (884) | (147) |
| Income (loss) before income taxes | $(659) | $608 | $(1033) | $1057 |

---

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Other Segment Information** | *Pack. & Spec. Plastics* | *Ind. Interm. & Infrast.* | *Perf. Materials & Coatings* | *Operating Segment Total* | *Corp.* <sup>1</sup> | *Total* |
| In millions | *Pack. & Spec. Plastics* | *Ind. Interm. & Infrast.* | *Perf. Materials & Coatings* | *Operating Segment Total* | *Corp.* <sup>1</sup> | *Total* |
| *Three months ended Jun 30, 2025* |  |  |  |  |  |  |
| Net sales | $5025 | $2786 | $2129 | $9940 | $164 | $10104 |
| Depreciation and amortization | $369 | $153 | $192 | $714 | $10 | $724 |
| Capital expenditures | $510 | $102 | $50 | $662 | $— | $662 |
| Operating EBIT | $71 | $(185) | $152 | $38 | $(59) | $(21) |
| *Three months ended Jun 30, 2024* |  |  |  |  |  |  |
| Net sales | $5515 | $2951 | $2243 | $10709 | $206 | $10915 |
| Depreciation and amortization | $343 | $141 | $191 | $675 | $7 | $682 |
| Capital expenditures | $475 | $170 | $78 | $723 | $— | $723 |
| Operating EBIT | $703 | $7 | $146 | $856 | $(37) | $819 |
| *Six months ended Jun 30, 2025* |  |  |  |  |  |  |
| Net sales | $10335 | $5641 | $4200 | $20176 | $359 | $20535 |
| Depreciation and amortization | $729 | $299 | $392 | $1420 | $18 | $1438 |
| Capital expenditures | $1025 | $231 | $91 | $1347 | $— | $1347 |
| Operating EBIT | $413 | $(313) | $201 | $301 | $(92) | $209 |
| *Six months ended Jun 30, 2024* |  |  |  |  |  |  |
| Net sales | $10945 | $5959 | $4395 | $21299 | $381 | $21680 |
| Depreciation and amortization | $714 | $288 | $384 | $1386 | $16 | $1402 |
| Capital expenditures | $944 | $332 | $161 | $1437 | $— | $1437 |
| Operating EBIT | $1308 | $94 | $187 | $1589 | $(96) | $1493 |

---

1. Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. Net sales for Corporate are primarily related to insurance operations. Corporate expenses are primarily related to insurance operations, salaries and wages and non-business aligned environmental and legal costs.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Segment Asset Information** | *Pack. & Spec. Plastics* | *Ind. Interm. & Infrast.* | *Perf. Materials & Coatings* | *Operating Segment Total* | *Corp.* | *Total* |
| In millions | *Pack. & Spec. Plastics* | *Ind. Interm. & Infrast.* | *Perf. Materials & Coatings* | *Operating Segment Total* | *Corp.* | *Total* |
| *Jun 30, 2025* |  |  |  |  |  |  |
| Total assets | $29791 | $12252 | $11585 | $53628 | $5363 | $58991 |
| Investments in nonconsolidated affiliates <sup>1</sup> | $686 | $386 | $145 | $1217 | $45 | $1262 |
| *Dec 31, 2024* |  |  |  |  |  |  |
| Total assets | $29034 | $11928 | $11170 | $52132 | $5180 | $57312 |
| Investments in nonconsolidated affiliates <sup>1</sup> | $711 | $367 | $146 | $1224 | $42 | $1266 |

---

1. See Note 10 for additional information regarding the Company's investments in nonconsolidated affiliates.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

The following tables summarize the pretax impact of significant items by segment excluded from Operating EBIT:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Significant Items by Segment** | | | | | | |
| In millions | *Pack. & Spec. Plastics* | *Ind. Interm. & Infrast.* | *Perf. Mat. & Coatings* | *Operating Segment Total* | *Corp.* | *Total* |
| *Three months ended Jun 30, 2025* |  |  |  |  |  |  |
| 2025 Restructuring Program severance and related benefit costs and asset related charges <sup>1</sup> | $(158) | $(89) | $(147) | $(394) | $(197) | $(591) |
| Implementation costs <sup>2</sup> |  |  |  |  | (5) | (5) |
| Net gain on divestitures and asset sale <sup>3</sup> |  | 103 |  | 103 |  | 103 |
| Litigation related charges, awards and adjustments <sup>4</sup> |  |  |  |  | 42 | 42 |
| Indemnification and other transaction related costs <sup>5</sup> |  |  |  |  | (17) | (17) |
| Total significant items by segment | $(158) | $14 | $(147) | $(291) | $(177) | $(468) |
| *Six months ended Jun 30, 2025* |  |  |  |  |  |  |
| Restructuring, implementation and efficiency costs, and asset related charges - net <sup>6</sup> | $— | $(1) | $— | $(1) | $(50) | $(51) |
| 2025 Restructuring Program severance and related benefit costs and asset related charges <sup>1</sup> | (158) | (89) | (147) | (394) | (404) | (798) |
| Implementation costs <sup>2</sup> |  |  |  |  | (5) | (5) |
| Net gain on divestitures and asset sale <sup>3</sup> |  | 103 |  | 103 |  | 103 |
| Litigation related charges, awards and adjustments <sup>4</sup> |  |  |  |  | 42 | 42 |
| Loss on early extinguishment of debt <sup>7</sup> |  |  |  |  | (60) | (60) |
| Indemnification and other transaction related costs <sup>5</sup> |  |  |  |  | (115) | (115) |
| Total significant items by segment | $(158) | $13 | $(147) | $(292) | $(592) | $(884) |

---

1. Severance and related benefit costs and impairment charges related to the write-down of certain manufacturing facilities, corporate assets, leased non-manufacturing facilities and other miscellaneous assets associated with the Company's 2025 Restructuring Program. See Note 5 for additional information.

2. Implementation costs associated with the Company's 2025 Restructuring Program and the sale of membership interests of the Company's wholly owned subsidiary, Diamond Infrastructure Solutions.

3. Related to a gain on the sale of the soil fumigation product line. See Note 4 for additional information.

4. Includes a gain associated with the reassessment of liabilities for certain accrued Groundwater Matters, partially offset by the settlement of a separate claim related to water storage district Groundwater Matters. See Note 14 for additional information.

5. Charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation. The six months ended June 30, 2025 also includes a charge related to an arbitration settlement agreement for historical product claims from a divested business. See Note 14 for additional information.

6. Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. The six months ended June 30, 2024 also includes impairment charges related to the write-down of certain manufacturing assets, partially offset by an asset related credit adjustment. See Note 5 for additional information.

7. The Company retired outstanding long-term debt resulting in a loss on early extinguishment. See Note 13 for additional information.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Significant Items by Segment** | *Pack. & Spec. Plastics* | *Ind. Interm. & Infrast.* | *Perf. Materials & Coatings* | *Operating Segment Total* | *Corp.* | *Total* |
| In millions | *Pack. & Spec. Plastics* | *Ind. Interm. & Infrast.* | *Perf. Materials & Coatings* | *Operating Segment Total* | *Corp.* | *Total* |
| *Three months ended Jun 30, 2024* |  |  |  |  |  |  |
| Restructuring, implementation and efficiency costs, and asset related charges - net <sup>1</sup> | $— | $— | $— | $— | $(56) | $(56) |
| *Six months ended Jun 30, 2024* |  |  |  |  |  |  |
| Restructuring, implementation and efficiency costs, and asset related charges - net <sup>1</sup> | $(37) | $(8) | $— | $(45) | $(102) | $(147) |

---

1. Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. The six months ended June 30, 2024 also includes impairment charges related to the write-down of certain manufacturing assets.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.**

This Quarterly Report on Form 10-Q is a combined report being filed by Dow Inc. and The Dow Chemical Company and its consolidated subsidiaries ("TDCC" and together with Dow Inc., "Dow" or the "Company") due to the parent/subsidiary relationship between Dow Inc. and TDCC. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Each of Dow Inc. and TDCC is filing information in this report on its own behalf and neither company makes any representation to the information relating to the other company.

Pursuant to General Instruction H(1)(a) and (b) for Form 10-Q "Omission of Information by Certain Wholly-Owned Subsidiaries," TDCC is filing this Form 10-Q with a reduced disclosure format.

Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation, a wholly owned subsidiary of the Company. Additionally, the term "Diamond Infrastructure Solutions" means Dow InfraCo, LLC, an entity that owns and operates infrastructure assets at certain Dow locations on the U.S. Gulf Coast and became a consolidated variable interest entity effective May 1, 2025. The term "EMEAI" refers to the geographic region of Europe, Middle East, Africa and India.

Dow's website and its content are not deemed incorporated by reference into this report.

**STATEMENT ON MACROECONOMIC CONDITIONS AND THIRD QUARTER OUTLOOK**

*Overview of Macroeconomic Conditions and the Company's Response*

The Company has continued to face challenging market conditions, including the significant impact of slower global GDP growth, through the second quarter of 2025. Industry overcapacity due to newer entrants exporting at anti-competitive economics has, and is expected to continue to, negatively impact the Company's results of operations and cash flows. In addition, the current uncertain geopolitical environment, including the impact of trade policies, has resulted in increased volatility in global markets, also negatively impacting the Company's results of operations and cash flows. The macroeconomic conditions and volatility experienced in the first six months of 2025 are expected to persist in the near term for the Company and the industry alike.

Despite these challenges, the Company has maintained a strong financial position and solid liquidity and has taken actions to mitigate impacts on its supply chain and results of operations. At the time of this filing, the ultimate impact of tariff policies and other rapidly evolving global trade measures, coupled with existing macroeconomic challenges, is uncertain. The Company is actively monitoring global trade developments to identify actions necessary to maintain competitiveness while it adapts to these new economic challenges. More information on the risks of tariffs and potential impact to the Company can be found in Part II, Item 1A. Risk Factors.

In the first quarter of 2025, Dow announced targeted cost actions to reduce structural costs by $1 billion over the next two years, while its businesses work to balance supply with profitable demand. The cost actions target areas such as third-party spending and include a workforce reduction of approximately 1,500 roles. The Company also announced reductions to its capital expenditures for 2025.

The Company announced further actions to address ongoing macroeconomic volatility and persistently slower global GDP growth in the second quarter of 2025, including the decision to delay construction of its Path2Zero project in Fort Saskatchewan, Alberta, Canada, until market conditions improve, reducing the Company's expected 2025 enterprise-wide capital expenditures to $2.5 billion, a reduction from the Company's original plan of $3.5 billion. Dow remains committed to its Path2Zero project and the growth upside it will enable in targeted applications like pressure pipe, wire and cable, and food packaging. The Path2Zero project is expected to be the world's first net-zero Scope 1 and 2 carbon dioxide equivalent emissions integrated ethylene and derivatives complex.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

On July 7, 2025, the Company announced additional restructuring actions, approved by its Board of Directors ("Board") on June 30, 2025, to rationalize its global asset footprint, including actions related to the three assets identified as part of the Company's expanded strategic review of its European assets and certain corporate and other assets, and to enhance the Company's competitiveness over the economic cycle. The program includes asset write-down and write-off charges, severance and related benefit costs, contract termination fees and other exit and disposal costs. These actions will be completed by the Company primarily over the next four years, including the asset shut downs and completion of the related decommissioning and demolition activities. Significant actions approved to date include the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Packaging & Specialty Plastics will shut down an ethylene facility in Böhlen, Germany by the end of 2027.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Industrial Intermediates & Infrastructure will shut down chlor-alkali and vinyl assets in Schkopau, Germany by the end of 2027.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Performance Materials & Coatings will shut down a basics siloxanes plant in Barry, United Kingdom by mid-year 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company will write-off certain Corporate-aligned owned and leased non-manufacturing facilities and other assets.

More information on the restructuring actions and related charges can be found in Note 5 to the Consolidated Financial Statements.

On July 24, 2025, the Company's Board declared a quarterly dividend of $0.35 per share, adjusting the dividend by 50 percent in response to the prolonged industry downturn. The adjustment to the size of the dividend reflects the Company's balanced capital allocation approach and enhances financial flexibility amidst a persistently challenging macroeconomic environment.

*Outlook*

Dow's strategic actions enable it to mitigate the dynamic factors that its industry is facing. However, signs of oversupply from newer market entrants who are exporting to various regions at anti-competitive economics require broader industry engagement and additional regulatory action to restore competitive dynamics. The commissioning of the Company's near-term growth projects, which are all operational in the third quarter of 2025, paired with its longer-term strategic investments, will increase Dow's position in higher-value applications in attractive end markets that are not exposed to this same level of anti-competitive activity. This will enable more resilient earnings and leading shareholder returns. Additionally, Dow is focused on structurally improving its cost base, optimizing its global asset footprint, and maintaining its track record of operational excellence to further strengthen the Company's competitive advantages.

**OVERVIEW**

The following is a summary of the results for the three months ended June 30, 2025:

• The Company reported net sales in the second quarter of 2025 of $10.1 billion, down 7 percent from $10.9 billion in the second quarter of 2024, and down in all operating segments; Packaging & Specialty Plastics (down 9 percent), Industrial Intermediates & Infrastructure (down 6 percent) and Performance Materials & Coatings (down 5 percent). Net sales decreased in all geographic regions; the U.S. & Canada (down 5 percent), EMEAI (down 8 percent), Latin America (down 12 percent) and Asia Pacific (down 9 percent).

• Local price decreased 7 percent compared with the second quarter of 2024, and was down in all operating segments; Packaging & Specialty Plastics (down 10 percent), Industrial Intermediates & Infrastructure (down 5 percent) and Performance Materials & Coatings (down 3 percent). Local price was down in all geographic regions; Latin America and Asia Pacific (both down 8 percent), EMEAI (down 7 percent) and the U.S. & Canada (down 6 percent).

• Volume decreased 1 percent compared with the second quarter of 2024 and was mixed by operating segment; Packaging & Specialty Plastics (up 1 percent), Industrial Intermediates & Infrastructure (down 2 percent) and Performance Materials & Coatings (down 3 percent). Volume increased in the U.S. & Canada (up 2 percent), and was more than offset by a decrease in EMEAI and Latin America (both down 3 percent) and Asia Pacific (down 1 percent).

• Currency had a favorable impact of 1 percent on net sales compared with the second quarter of 2024, driven by EMEAI (up 2 percent) and Asia Pacific (up 1 percent).

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

• Restructuring and asset related charges - net were $591 million in the second quarter of 2025. The restructuring charges primarily consisted of asset write-downs and write-offs of $334 million, severance and related benefit costs of $154 million and exit and disposals costs of $103 million related to asset actions, primarily in Europe, approved by the Board on June 30, 2025.

*•* Equity in losses of nonconsolidated affiliates was $30 million in the second quarter of 2025, compared with equity in earnings of nonconsolidated affiliates of $26 million in the second quarter of 2024, primarily due to lower results at the Company's Thai, Kuwait and non-principal joint ventures, partially offset by improved results at the Sadara joint venture.

• Net income (loss) available for Dow Inc. and TDCC common stockholder(s) was a loss of $835 million and $816 million, respectively, in the second quarter of 2025, compared with income of $439 million and $441 million, respectively, in the second quarter of 2024. Earnings (loss) per share for Dow Inc. was a loss of $1.18 per share in the second quarter of 2025, compared with earnings of $0.62 per share in the second quarter of 2024.

• Cash provided by (used for) operating activities - continuing operations was a use of $470 million in the second quarter of 2025, compared with a source of $832 million in the second quarter of 2024. Cash provided by (used for) operating activities - continuing operations was down $574 million compared with the first quarter of 2025.

• On April 10, 2025, Dow Inc. announced that its Board declared a dividend of $0.70 per share, payable on June 13, 2025, to shareholders of record as of May 30, 2025. This marks the 455th consecutive dividend paid by the Company or its affiliates since 1912.

• On April 10, 2025, Dow Inc. announced results from the 2025 Annual Stockholder Meeting, including the election of all incumbent directors, as well as Rebecca B. Liebert, president and chief executive officer of The Lubrizol Corporation, a Berkshire Hathaway company, to its Board.

• On May 1, 2025, the Company completed the sale of 40 percent of the membership interests in its wholly owned subsidiary Diamond Infrastructure Solutions to InfraPark Holdings, LLC ("InfraPark"), a subsidiary of a fund managed by Macquarie Asset Management. Dow received initial cash proceeds of approximately $2.4 billion from the sale. InfraPark has the option to purchase up to an additional 9 percent of Diamond Infrastructure Solutions' member interests in exchange for additional cash proceeds of up to $600 million within six months of the closing date of the sale.

• On May 1, 2025, the Company announced the completion of the sale of Telone<sup>TM</sup>, a soil fumigation product line, to TriCal Soil Solutions, Inc., a distributor and applicator of soil fumigation products for net cash proceeds of $121 million.

• On June 2, 2025, the Company announced it signed a sale and purchase agreement to sell its 50 percent interest in DowAksa Advanced Composites Holdings BV ("DowAksa") to its joint venture partner, Aksa Akrilik Kimya Sanayii A.Ş., for approximately $125 million. The Company is targeting to close the transaction in the third quarter of 2025.

• On June 10, 2025, The Court of King's Bench of Alberta, Canada signed a judgment ordering Nova Chemicals Corporation to pay the Company an additional amount of $1.62 billion Canadian dollars (equivalent to approximately $1.2 billion U.S. dollars) for damages the Company incurred through June 2018, which had not been previously quantified.

• On June 30, 2025, the Board approved restructuring actions to rationalize the Company's global asset footprint, including certain actions identified as part of the Company's previously announced strategic review of its European assets, and certain corporate and other assets.

In addition, the following events occurred subsequent to the second quarter of 2025:

*•* On July 7, 2025, Moody's Ratings announced a long-term credit rating change for TDCC from Baa1 to Baa2 and affirmed TDCC's P-2 rating and its outlook of negative.

• On July 24, 2025, Dow Inc. announced that its Board declared a dividend of $0.35 per share, payable on September 12, 2025, to shareholders of record as of August 29, 2025. This marks the 456th consecutive dividend paid by the Company or its affiliates since 1912.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**RESULTS OF OPERATIONS**

**Net Sales**

The following tables summarize net sales and sales variances by operating segment and geographic region from the prior year:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Summary of Sales Results** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| Net sales | $10104 | $10915 | $20535 | $21680 |

---

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Sales Variances by Operating Segment and Geographic Region** | *Three Months Ended Jun 30, 2025* | *Three Months Ended Jun 30, 2025* | *Three Months Ended Jun 30, 2025* | *Three Months Ended Jun 30, 2025* | *Three Months Ended Jun 30, 2025* | *Six Months Ended Jun 30, 2025* | *Six Months Ended Jun 30, 2025* | *Six Months Ended Jun 30, 2025* | *Six Months Ended Jun 30, 2025* | *Six Months Ended Jun 30, 2025* |
| **Sales Variances by Operating Segment and Geographic Region** | *Local Price & Product Mix* | *Currency* | *Volume* | *Portfolio & Other* <sup>1</sup> | *Total* | *Local Price & Product Mix* | *Currency* | *Volume* | *Portfolio & Other* <sup>1</sup> | *Total* |
| Percentage change from prior year | *Local Price & Product Mix* | *Currency* | *Volume* | *Portfolio & Other* <sup>1</sup> | *Total* | *Local Price & Product Mix* | *Currency* | *Volume* | *Portfolio & Other* <sup>1</sup> | *Total* |
| Packaging & Specialty Plastics | (10)% | 1% | 1% | (1)% | (9)% | (7)% | —% | 2% | (1)% | (6)% |
| Industrial Intermediates & Infrastructure | (5) | 1 | (2) |  | (6) | (4) |  | (1) |  | (5) |
| Performance Materials & Coatings | (3) | 1 | (3) |  | (5) | (2) |  | (2) |  | (4) |
| Total | (7)% | 1% | (1)% | —% | (7)% | (5)% | —% | 1% | (1)% | (5)% |
| Total, excluding the Hydrocarbons & Energy business | (6)% | 1% | (2)% | (1)% | (8)% | (5)% | —% | —% | (1)% | (6)% |
| U.S. & Canada | (6)% | —% | 2% | (1)% | (5)% | (4)% | —% | 3% | —% | (1)% |
| EMEAI | (7) | 2 | (3) |  | (8) | (5) |  | (1) | (1) | (7) |
| Asia Pacific | (8) | 1 | (1) | (1) | (9) | (7) |  | 1 |  | (6) |
| Latin America | (8) |  | (3) | (1) | (12) | (8) |  | (4) |  | (12) |
| Total | (7)% | 1% | (1)% | —% | (7)% | (5)% | —% | 1% | (1)% | (5)% |

---

1. Portfolio & Other includes the sales impact of the flexible packaging laminating adhesives business, which was sold to Arkema S.A. in the fourth quarter of 2024.

Net sales in the second quarter of 2025 were $10.1 billion, down 7 percent from $10.9 billion in the second quarter of 2024, with local price down 7 percent, volume down 1 percent, and a favorable currency impact of 1 percent. Net sales decreased in all operating segments and all geographic regions. Local price decreased in all geographic regions and in Packaging & Specialty Plastics (down 10 percent), Industrial Intermediates & Infrastructure (down 5 percent), and Performance Materials & Coatings (down 3 percent). Volume decreased 1 percent, driven by EMEAI and Latin America (both down 3 percent) and Asia Pacific (down 1 percent), partially offset by an increase in the U.S. & Canada (up 2 percent). Volume increased in Packaging & Specialty Plastics (up 1 percent) and decreased in Industrial Intermediates & Infrastructure (down 2 percent) and Performance Materials & Coatings (down 3 percent). Currency favorably impacted net sales by 1 percent, driven by EMEAI (up 2 percent) and Asia Pacific (up 1 percent). Portfolio & other unfavorably impacted net sales in Packaging & Specialty Plastics (down 1 percent). Excluding the Hydrocarbons & Energy business, net sales decreased 8 percent.

Net sales for the first six months of 2025 were $20.5 billion, down 5 percent from $21.7 billion in the same period last year, with local price down 5 percent, portfolio & other down 1 percent, and volume up 1 percent. Net sales decreased in all operating segments and all geographic regions. Local price decreased in all geographic regions and in Packaging & Specialty Plastics (down 7 percent), Industrial Intermediates & Infrastructure (down 4 percent), and Performance Materials & Coatings (down 2 percent). Volume increased 1 percent, driven by the U.S. & Canada (up 3 percent) and Asia Pacific (up 1 percent), partially offset by declines in Latin America (down 4 percent) and EMEAI (down 1 percent). Volume increased in Packaging & Specialty Plastics (up 2 percent) and decreased in Industrial Intermediates & Infrastructure (down 1 percent) and Performance Materials & Coatings (down 2 percent). Excluding the Hydrocarbons & Energy business, net sales decreased 6 percent.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Cost of Sales**

Cost of sales ("COS") was $9.5 billion in the second quarter of 2025, compared with $9.6 billion in the second quarter of 2024. COS decreased in the second quarter of 2025 primarily due to lower raw material and feedstock costs, decreased planned maintenance turnaround spending, adjustments to legacy groundwater contamination matters and the impact of the Company's cost reduction initiatives, partially offset by the impact of lower operating rates. For the first six months of 2025, COS was $19.3 billion, compared with $19.1 billion in the first six months of 2024. COS for the first six months of 2025 increased primarily due to the impact of lower operating rates and a charge related to an arbitration settlement agreement for historical product claims from a divested business, partially offset by adjustments to legacy groundwater contamination matters, lower raw material and feedstock costs and decreased planned maintenance turnaround spending. COS as a percentage of net sales was 94.2 percent in the second quarter of 2025 (87.9 percent in the second quarter of 2024) and 93.9 percent for the first six months of 2025 (88.0 percent for the first six months of 2024).

**Research and Development Expenses**

Research and development ("R&D") expenses totaled $188 million in the second quarter of 2025, compared with $196 million in the second quarter of 2024. R&D expenses for the first six months of 2025 were $388 million, compared with $400 million in the first six months of 2024. R&D expenses for the three and six months ended June 30, 2025 decreased primarily due to the Company's cost reduction initiatives.

**Selling, General and Administrative Expenses**

Selling, general and administrative ("SG&A") expenses totaled $347 million in the second quarter of 2025, compared with $390 million in the second quarter of 2024. SG&A expenses decreased in the second quarter of 2025 primarily due to the impact of lower third-party purchased services. For the first six months of 2025, SG&A expenses were $713 million, compared with $832 million in the first six months of 2024. SG&A expenses for the first six months of 2025 decreased primarily due to lower third-party purchased services and decreased bad debt expense, including the impact of a favorable resolution of a dispute with a customer.

**Amortization of Intangibles**

Amortization of intangibles was $63 million in the second quarter of 2025 compared with $77 million in the second quarter of 2024. In the first six months of 2025, amortization of intangibles was $139 million, compared with $158 million in the first six months of 2024. Amortization of intangibles decreased primarily due to certain intangible assets becoming fully amortized in 2025.

**Restructuring and Asset Related Charges - Net**

*2025 Restructuring Program*

On January 27, 2025, the Board approved targeted actions to further achieve the Company's cost reduction initiatives in response to ongoing macroeconomic uncertainty, while reinforcing its long-term competitiveness across the economic cycle. As a result of these actions, in the first quarter of 2025 the Company recorded pretax charges of $207 million for severance and related benefits costs, related to Corporate. These actions are expected to be substantially complete by the end of 2026. See Note 5 to the Consolidated Financial Statements for additional information.

On June 30, 2025, the Board approved restructuring actions to rationalize the Company's global asset footprint, including certain actions identified as part of the Company's previously announced strategic review of its European assets and certain corporate and other assets, and to enhance the Company's competitiveness over the economic cycle. The program includes asset write-down and write-off charges, severance and related benefit costs and other exit and disposal costs. As a result of these actions, in the second quarter of 2025 the Company recorded pretax restructuring charges of $591 million, consisting of severance and related benefit costs of $154 million, asset write-downs and write-offs of $334 million and costs associated with exit and disposal activities of $103 million. Restructuring charges by segment were as follows: $158 million in Packaging & Specialty Plastics, $89 million in Industrial Intermediates & Infrastructure, $147 million in Performance Materials & Coatings and $197 million in Corporate. See Note 5 to the Consolidated Financial Statements for additional information.

*2023 Restructuring Program*

Actions related to the restructuring program approved by the Board on January 25, 2023 were complete at the end of the second quarter of 2025. In the first quarter of 2025, the Company recorded an additional pretax restructuring charge of $5 million for asset write-downs and write-offs and an asset related credit adjustment of $4 million, related to Industrial Intermediates & Infrastructure. See Note 5 to the Consolidated Financial Statements for additional information.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Equity in Earnings (Losses) of Nonconsolidated Affiliates**

The Company's share of equity in losses of nonconsolidated affiliates was $30 million in the second quarter of 2025, compared with equity in earnings of nonconsolidated affiliates of $26 million in the second quarter of 2024. The Company's share of equity in losses of nonconsolidated affiliates was $50 million for the first six months of 2025, compared with equity in earnings of nonconsolidated affiliates of $43 million for the first six months of 2024. The decrease in both periods was primarily driven by lower results at the Company's Thai, Kuwait and non-principal joint ventures, partially offset by improved results at the Sadara joint venture. Cash dividends from nonconsolidated affiliates were $170 million for the first six months of 2025, compared with $199 million for the first six months of 2024.

**Sundry Income (Expense) – Net**

Sundry income (expense) - net for the three months ended June 30, 2025 was income of $147 million and $163 million for Dow Inc. and TDCC, respectively, compared with income of $76 million and $74 million, respectively, for the three months ended June 30, 2024. The second quarter of 2025 included a gain from the divestiture of the Company's soil fumigation product line, non-operating pension and postretirement benefit plan credits, and foreign currency exchange gains. The second quarter of 2024 included non-operating pension and postretirement benefit plan credits, gains on the sales of assets and investments and foreign currency exchange losses. See Note 6 to the Consolidated Financial Statements for additional information.

Sundry income (expense) - net for the six months ended June 30, 2025 was income of $160 million and $176 million for Dow Inc. and TDCC, respectively, compared with income of $137 million and $135 million, respectively, for the six months ended June 30, 2024. The first six months of 2025 included a gain from the divestiture of the Company's soil fumigation product line, non-operating pension and postretirement benefit plan credits, and foreign currency exchange gains, partially offset by a loss on early extinguishment of debt. The first six months of 2024 included non-operating pension and postretirement benefit plan credits and gains on the sales of assets and investments, partially offset by foreign currency exchange losses. See Note 6 to the Consolidated Financial Statements for additional information.

**Interest Expense and Amortization of Debt Discount**

Interest expense and amortization of debt discount was $209 million in the second quarter of 2025, compared with $197 million in the second quarter of 2024. Interest expense and amortization of debt discount was $425 million in the first six months of 2025, compared with $396 million in the first six months of 2024. The increase in interest expense is primarily due to increased issuances of commercial paper during the first six months of 2025. See Liquidity and Capital Resources in Management's Discussion and Analysis of Financial Condition and Results of Operations and Note 13 to the Consolidated Financial Statements for additional information.

**Provision for Income Taxes**

The Company's effective tax rate fluctuates based on, among other factors, where income is earned, the level of income relative to tax attributes and the level of equity earnings, since most earnings from the Company's equity method investments are taxed at the joint venture level. In the second quarter of 2025, the Company reported a provision for income taxes of $142 million, resulting in a negative effective tax rate of 21.5 percent and 22.2 percent for Dow Inc. and TDCC, respectively. In the second quarter of 2024, the Company reported a provision for income taxes of $150 million, resulting in an effective tax rate of 24.7 percent and 24.6 percent for Dow Inc. and TDCC, respectively. For the first six months of 2025, the Company reported a provision for income taxes of $58 million, resulting in a negative effective tax rate of 5.6 percent and 5.7 percent for Dow Inc. and TDCC, respectively. For the first six months of 2024, the Company reported a provision for income taxes of $61 million, resulting in an effective tax rate of 5.8 percent and 5.7 percent for Dow Inc. and TDCC, respectively.

The provision for income taxes for the three and six months ended June 30, 2025 was unfavorably impacted by the recording of valuation allowances in certain foreign jurisdictions of $242 million as well as losses attributable to jurisdictions for which no tax benefit can be recognized, and a tax credit of $89 million related to the sale of a portion of the Company's membership interest in its wholly owned subsidiary, Diamond Infrastructure Solutions, resulting in a negative effective tax rate for both periods. See Note 17 to the Consolidated Financial Statements for additional information related to the Diamond Infrastructure Solutions transaction. In the first quarter of 2024, the Company recorded a tax credit of $194 million related to a reassessment of interest and penalties on a tax matter in a foreign jurisdiction, resulting in a reduced effective tax rate for the first six months of 2024.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

The Company continues to monitor and evaluate legislative developments related to the Global Anti-Base Erosion Proposal Regime ("GloBE") established by the Organization of Economic Cooperation and Development's ("OECD") Pillar Two framework. Several countries in which the Company operates have adopted GloBE into their legislation and several others are expected to enact these rules in the future. To date, such legislation has not materially impacted the Company's effective tax rate.

On July 4, 2025, U.S. legislation formally titled "An Act to Provide for Reconciliation Pursuant to Title II of H. Con. Res. 14" ("The Act") and commonly referred to as the One Big Beautiful Bill Act was signed into law. The Act, among other things, extended key provisions of the 2017 Tax Cuts and Jobs Act and introduced targeted changes to the U.S. federal income tax regime. The Company is currently evaluating the impact of The Act on its results of operations and will recognize the related tax impacts in the period of enactment.

**Net Income Attributable to Noncontrolling Interests**

Net income attributable to noncontrolling interests was $34 million in the second quarter of 2025, compared with $19 million in the second quarter of 2024. Net income attributable to noncontrolling interests was $51 million in the first six months of 2025, compared with $41 million for the first six months of 2024. The increase in net income attributable to noncontrolling interests was primarily driven by the sale of 40 percent of the membership interests of the Company's wholly owned subsidiary, Diamond Infrastructure Solutions, in the second quarter of 2025. See Notes 17 and 22 to the Consolidated Financial Statements for additional information.

**Net Income (Loss) Available for Common Stockholder(s)**

*Dow Inc.*

Net income (loss) available for Dow Inc. common stockholders was a loss of $835 million, or $1.18 per share, in the second quarter of 2025, compared with income of $439 million, or $0.62 per share, in the second quarter of 2024. Net income (loss) available for Dow Inc. common stockholders was a loss of $1,142 million, or $1.62 per share, in the first six months of 2025, compared with income of $955 million, or $1.35 per share, in the first six months of 2024. See Note 8 to the Consolidated Financial Statements for details on Dow Inc.'s earnings per share calculations.

*TDCC*

Net income (loss) available for the TDCC common stockholder was a loss of $816 million in the second quarter of 2025, compared with income of $441 million in the second quarter of 2024. Net income (loss) available for the TDCC common stockholder was a loss of $1,121 million in the first six months of 2025, compared with income of $962 million in the first six months of 2024. TDCC's common shares are owned solely by Dow Inc.

**SEGMENT RESULTS**

For further discussion of the Company's segments, see Part I, Item 1. Business of the combined Dow Inc. and TDCC Annual Report on Form 10-K for the fiscal year ended December 31, 2024 ("2024 10-K"), filed with the SEC on February 4, 2025.

Dow's measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the chief executive officer, chief operating officer, chief financial officer, general counsel and corporate secretary, and senior vice president of corporate development, together the "executive committee" and chief operating decision maker ("CODM"), assesses performance and allocates resources. The CODM compares quarterly results to both the year-ago and sequential periods to assess performance and allocate resources to each segment. The Company defines Operating EBIT as earnings (i.e., "Income (loss) before income taxes") before interest, excluding the impact of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate. See Note 23 to the Consolidated Financial Statements for reconciliations of these measures.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**PACKAGING & SPECIALTY PLASTICS**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Packaging & Specialty Plastics** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| Net sales | $5025 | $5515 | $10335 | $10945 |
| Operating EBIT | $71 | $703 | $413 | $1308 |
| Equity earnings | $7 | $55 | $46 | $80 |

---

---

| | | |
|:---|:---|:---|
| **Packaging & Specialty Plastics** | *Three Months Ended* | *Six Months Ended* |
| Percentage change from prior year | *Jun 30, 2025* | *Jun 30, 2025* |
| *Change in Net Sales from Prior Period due to:* |  |  |
| &nbsp;&nbsp;&nbsp;Local price & product mix | (10)% | (7)% |
| &nbsp;&nbsp;&nbsp;Currency | 1 |  |
| &nbsp;&nbsp;&nbsp;Volume | 1 | 2 |
| &nbsp;&nbsp;&nbsp;Portfolio & other <sup>1</sup> | (1) | (1) |
| &nbsp;&nbsp;&nbsp;Total | (9)% | (6)% |

---

1. Portfolio & other includes the sales impact of the flexible packaging laminating adhesives business, which was sold to Arkema S.A. in the fourth quarter of 2024.

Packaging & Specialty Plastics net sales were $5,025 million in the second quarter of 2025, down 9 percent from net sales of $5,515 million in the second quarter of 2024, with local price down 10 percent, portfolio & other down 1 percent and both volume and currency up 1 percent. Local price decreased in Packaging and Specialty Plastics in all geographic regions, driven by lower pricing of polyethylene and functional polymers. Local price decreased in Hydrocarbons & Energy, driven by EMEAI and the U.S. & Canada and primarily in aromatics. Volume decreased in Packaging and Specialty Plastics, in all geographic regions except EMEAI, driven by lower volumes in functional polymers and a decrease in nonrecurring licensing sales, partially offset by higher polyethylene volumes. Volume increased in Hydrocarbons & Energy, primarily due to higher energy sales in the U.S. & Canada. Currency had a favorable impact on sales in both businesses and was primarily driven by EMEAI.

Operating EBIT was $71 million in the second quarter of 2025, down $632 million from Operating EBIT of $703 million in the second quarter of 2024. Operating EBIT decreased primarily due to lower integrated margins and equity earnings at the Company's non-principal, EQUATE and Thai joint ventures, which were partially offset by the impact of the Company's cost reduction initiatives and lower planned maintenance costs.

Packaging & Specialty Plastics net sales were $10,335 million in the first six months of 2025, down 6 percent from net sales of $10,945 million in the first six months of 2024, with local price down 7 percent, portfolio & other down 1 percent, and volume up 2 percent. Local price decreased in Packaging and Specialty Plastics in all geographic regions, primarily driven by lower pricing of polyethylene and functional polymers. Local price decreased in Hydrocarbons & Energy, driven by EMEAI and the U.S. & Canada and primarily in aromatics. Volume increased in Packaging and Specialty Plastics, with higher volumes in Asia Pacific and EMEAI partially offset by a decline in Latin America, driven by an increase in nonrecurring licensing sales partially offset by lower functional polymers volumes. Volume increased in Hydrocarbons & Energy, primarily due to higher energy sales in the U.S. & Canada.

Operating EBIT was $413 million in the first six months of 2025, down $895 million from Operating EBIT of $1,308 million in the first six months of 2024. Operating EBIT decreased primarily due to lower integrated margins, partially offset by lower planned maintenance costs.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**INDUSTRIAL INTERMEDIATES & INFRASTRUCTURE**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Industrial Intermediates & Infrastructure** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| Net sales | $2786 | $2951 | $5641 | $5959 |
| Operating EBIT | $(185) | $7 | $(313) | $94 |
| Equity losses | $(39) | $(31) | $(97) | $(46) |

---

---

| | | |
|:---|:---|:---|
| **Industrial Intermediates & Infrastructure** | *Three Months Ended* | *Six Months Ended* |
| Percentage change from prior year | *Jun 30, 2025* | *Jun 30, 2025* |
| *Change in Net Sales from Prior Period due to:* |  |  |
| &nbsp;&nbsp;&nbsp;Local price & product mix | (5)% | (4)% |
| &nbsp;&nbsp;&nbsp;Currency | 1 |  |
| &nbsp;&nbsp;&nbsp;Volume | (2) | (1) |
| &nbsp;&nbsp;&nbsp;Total | (6)% | (5)% |

---

Industrial Intermediates & Infrastructure net sales were $2,786 million in the second quarter of 2025, down 6 percent from net sales of $2,951 million in the second quarter of 2024, with local price down 5 percent, volume down 2 percent and a favorable currency impact of 1 percent. Local price decreased in both businesses, led by declines in Asia Pacific and EMEAI and in consumer durables, industrial, and building and construction applications. Volume decreased in Polyurethanes & Construction Chemicals, primarily in EMEAI, and was driven by lower demand, particularly in industrial applications. Volume increased in Industrial Solutions, with higher volumes in the U.S. & Canada and EMEAI partially offset by a decline in Asia Pacific, and was primarily driven by increased demand for energy applications. Currency had a favorable impact on sales in both businesses and was driven by EMEAI and Asia Pacific.

Operating EBIT was a loss of $185 million in the second quarter of 2025, down $192 million from Operating EBIT of $7 million in the second quarter of 2024. Operating EBIT decreased primarily driven by lower selling prices in both businesses and higher planned maintenance activity, partially offset by the impact of the Company's cost reduction initiatives.

Industrial Intermediates & Infrastructure net sales were $5,641 million in the first six months of 2025, down 5 percent from net sales of $5,959 million in the first six months of 2024, with local price down 4 percent and volume down 1 percent. Local price decreased in both businesses and across all geographic regions, led by industrial, consumer durables and building and construction applications. Volume decreased in Polyurethanes & Construction Chemicals, driven by declines in EMEAI and Latin America, primarily in industrial, mobility and consumer durables applications. Volume increased in Industrial Solutions, with higher volumes in the U.S. & Canada and EMEAI primarily in energy and industrial applications..

Operating EBIT was a loss of $313 million in the first six months of 2025, down $407 million from Operating EBIT of $94 million in the first six months of 2024. Operating EBIT decreased primarily due to margin compression, higher planned maintenance activity and lower results at the EQUATE and Sadara joint ventures.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**PERFORMANCE MATERIALS & COATINGS**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Performance Materials & Coatings** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| Net sales | $2129 | $2243 | $4200 | $4395 |
| Operating EBIT | $152 | $146 | $201 | $187 |
| Equity earnings | $1 | $2 | $1 | $8 |

---

---

| | | |
|:---|:---|:---|
| **Performance Materials & Coatings** | *Three Months Ended* | *Six Months Ended* |
| Percentage change from prior year | *Jun 30, 2025* | *Jun 30, 2025* |
| *Change in Net Sales from Prior Period due to:* |  |  |
| &nbsp;&nbsp;&nbsp;Local price & product mix | (3)% | (2)% |
| &nbsp;&nbsp;&nbsp;Currency | 1 |  |
| &nbsp;&nbsp;&nbsp;Volume | (3) | (2) |
| &nbsp;&nbsp;&nbsp;Total | (5)% | (4)% |

---

Performance Materials & Coatings net sales were $2,129 million in the second quarter of 2025, down 5 percent from net sales of $2,243 million in the second quarter of 2024, with local price and volume both down 3 percent and a favorable currency impact of 1 percent. Consumer Solutions local price decreased across all geographic regions, led by consumer and electronics and building and infrastructure applications. Local price decreased in Coatings & Performance Monomers in all geographic regions, led by acrylic monomers. Volume decreased in Consumer Solutions, driven by EMEAI and Asia Pacific. Volume declined in upstream siloxanes, partially offset by gains in downstream silicones, led by consumer and electronics applications. Volume decreased in Coatings & Performance Monomers in all geographic regions, primarily driven by lower demand for coatings applications, as building and construction end-markets continue to be challenged. The favorable currency impact was driven by EMEAI and Asia Pacific in both businesses.

Operating EBIT was $152 million in the second quarter of 2025, up $6 million from Operating EBIT of $146 million in the second quarter of 2024. Operating EBIT increased primarily due to margin expansion from lower input costs and the impact of the Company's cost reduction initiatives, partially offset by lower volumes in both businesses.

Performance Materials & Coatings net sales were $4,200 million in the first six months of 2025 compared with net sales of $4,395 million in the first six months of 2024, with local price and volume both down 2 percent. Consumer Solutions local price decreased across all geographic regions and was broad-based across end-markets. Local price decreased in Coatings & Performance Monomers in all geographic regions, primarily in acrylic monomers and architectural coatings. Volume decreased in Consumer Solutions with declines in EMEAI and Asia Pacific, while the U.S. & Canada and Latin America were flat. Volume decreased in upstream siloxanes, partially offset by an increase in downstream silicones, led by consumer and electronics applications. Volume decreased in Coatings & Performance Monomers in all geographic region except the U.S. & Canada, driven by lower demand for acrylic monomers and architectural coatings.

Operating EBIT was $201 million in the first six months of 2025, up $14 million from Operating EBIT of $187 million in the first six months of 2024. Operating EBIT increased primarily due to lower selling, general and administrative and research and development expenses and lower planned maintenance costs, partially offset by margin compression in both businesses and lower equity earnings.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**CORPORATE**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Corporate** | *Three Months Ended* | *Three Months Ended* | *Six Months Ended* | *Six Months Ended* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| Net sales | $164 | $206 | $359 | $381 |
| Operating EBIT | $(59) | $(37) | $(92) | $(96) |
| Equity earnings | $1 | $— | $— | $1 |

---

Net sales for Corporate, which primarily relate to the Company's insurance operations, were $164 million in the second quarter of 2025, a decrease from net sales of $206 million in the second quarter of 2024. Net sales were $359 million in the first six months of 2025, a decrease from net sales of $381 million in the first six months of 2024.

Operating EBIT was a loss of $59 million in the second quarter of 2025, compared with a loss of $37 million in the second quarter of 2024. Operating EBIT decreased primarily due to lower income from insurance operations. Operating EBIT was a loss of $92 million in the first six months of 2025, compared with a loss of $96 million in the first six months of 2024. Operating EBIT improved primarily due to lower environmental costs.

**CHANGES IN FINANCIAL CONDITION**

The Company had cash and cash equivalents of $2,399 million at June 30, 2025 and $2,189 million at December 31, 2024, of which $1,344 million at June 30, 2025 and $1,427 million at December 31, 2024 was held by subsidiaries in foreign countries, including U.S. territories. For each of its foreign subsidiaries, Dow makes an assertion regarding the amount of earnings intended for permanent reinvestment, with the balance available to be repatriated to the United States.

Cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries' operational activities and future foreign investments. Dow has the ability to repatriate additional funds to the United States, which could result in an adjustment to the tax liability for foreign withholding taxes, foreign and/or U.S. state income taxes and the impact of foreign currency movements. At June 30, 2025, management believed that sufficient liquidity was available in the United States. The Company has and expects to continue repatriating certain funds from its non-U.S. subsidiaries that are not needed to finance local operations; however, these particular repatriation activities have not and are not expected to result in a significant incremental tax liability to the Company.

The Company's cash flows from operating, investing and financing activities, as reflected in the consolidated statements of cash flows, are summarized in the following table:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Cash Flow Summary** | *Dow Inc.* | *Dow Inc.* | *TDCC* | *TDCC* |
|  | *Six Months Ended* | *Six Months Ended* | *Six Months Ended* | *Six Months Ended* |
|  | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* | *Jun 30, 2025* | *Jun 30, 2024* |
| Cash provided by (used for): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Operating activities - continuing operations | $(366) | $1292 | $(384) | $1300 |
| &nbsp;&nbsp;&nbsp;Operating activities - discontinued operations | (13) | 8 |  |  |
| &nbsp;&nbsp;&nbsp;Operating activities | $(379) | $1300 | $(384) | $1300 |
| &nbsp;&nbsp;&nbsp;Investing activities | $(962) | $(765) | $(962) | $(765) |
| &nbsp;&nbsp;&nbsp;Financing activities | $1341 | $(129) | $1346 | $(129) |

---

*Cash Flows from Operating Activities*

Cash used for operating activities from continuing operations in the first six months of 2025 was primarily driven by cash used for working capital and performance-based compensation, which were partly offset by the Company's cash earnings and dividends from equity method investments. Cash provided by operating activities from continuing operations in the first six months of 2024 was primarily driven by the Company's cash earnings and dividends from equity method investments, which were partially offset by cash used for working capital and performance-based compensation payments.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Net Working Capital** | *Dow Inc.* | *Dow Inc.* | *TDCC* | *TDCC* |
|  | *Jun 30, 2025* | *Dec 31, 2024* | *Jun 30, 2025* | *Dec 31, 2024* |
| In millions | *Jun 30, 2025* | *Dec 31, 2024* | *Jun 30, 2025* | *Dec 31, 2024* |
| Current assets | $17712 | $16590 | $17683 | $16565 |
| Current liabilities | 10486 | 10288 | 10382 | 10210 |
| Net working capital | $7226 | $6302 | $7301 | $6355 |
| Current ratio | 1.69:1 | 1.61:1 | 1.70:1 | 1.62:1 |

---

---

| | | | |
|:---|:---|:---|:---|
| **Working Capital Metrics** | *Three Months Ended* | *Three Months Ended* | *Three Months Ended* |
|  | *Jun 30, 2025* | *Mar 31, 2025* | *Jun 30, 2024* |
|  | *Jun 30, 2025* | *Mar 31, 2025* | *Jun 30, 2024* |
| Days sales outstanding in trade receivables | 47 | 42 | 43 |
| Days sales in inventory | 64 | 61 | 61 |
| Days payables outstanding | 64 | 59 | 65 |

---

Cash provided by operating activities from discontinued operations in the first six months of 2025 and 2024 reflected cash payments and receipts for certain agreements and matters related to the separation from DowDuPont Inc. ("DowDuPont").

*Cash Flows from Investing Activities*

Cash used for investing activities in the first six months of 2025 and 2024 was primarily for capital expenditures and purchases of investments, which were partially offset by proceeds from sales and maturities of investments. The first six months of 2025 also included a cash inflow related to the sale of the soil fumigation product line and certain related assets.

The Company's capital expenditures were $1,347 million in the first six months of 2025, compared with $1,437 million in the first six months of 2024. The Company has reduced its expected full year capital spending to approximately $2.5 billion. The primary driver for the decrease is the Company's decision to delay construction of the Fort Saskatchewan Path2Zero project until market conditions improve. As evidenced across this and prior economic cycles, the Company will proactively adjust its spending as economic conditions evolve.

*Cash Flows from Financing Activities*

Cash provided by financing activities in the first six months of 2025 was primarily related to proceeds from the sale of a minority stake in the Company's consolidated infrastructure entity and proceeds from the issuance of long-term debt, which were partially offset by payments on long-term debt. In addition, Dow Inc. included cash outflows for dividends paid to stockholders and TDCC included cash outflows for dividends paid to Dow Inc. Cash used for financing activities in the first six months of 2024 for Dow Inc. was primarily related to dividends paid to stockholders, purchases of treasury stock and payments on long-term debt, which were partially offset by proceeds from issuance of long-term debt. Cash used for financing activities in the first six months of 2024 for TDCC was primarily related to dividends paid to Dow Inc. and payments on long-term debt, which were partially offset by proceeds from issuance of long-term debt.

**Dow Inc. Non-GAAP Cash Flow Measures**

*Free Cash Flow* 

Dow defines Free Cash Flow as "Cash provided by (used for) operating activities - continuing operations," less capital expenditures. Under this definition, Free Cash Flow represents the cash generated by Dow from operations after investing in its asset base. Free Cash Flow, combined with cash balances and other sources of liquidity, represents the cash available to fund obligations and provide returns to shareholders. Free Cash Flow is an integral financial measure used in the Company's financial planning process.

*Operating EBITDA*

Dow defines Operating EBITDA as earnings (i.e., "Income (loss) before income taxes") before interest, depreciation and amortization, excluding the impact of significant items.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

*Cash Flow Conversion (Cash Flow from Operations to Operating EBITDA)*

Dow defines Cash Flow Conversion (Cash Flow from Operations to Operating EBITDA) as "Cash provided by (used for) operating activities - continuing operations," divided by Operating EBITDA. Management believes Cash Flow Conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings into cash flow.

These financial measures are not recognized in accordance with accounting principles generally accepted in the United States of America ("GAAP") and should not be viewed as alternatives to GAAP financial measures of performance. All companies do not calculate non-GAAP financial measures in the same manner and, accordingly, Dow's definitions may not be consistent with the methodologies used by other companies.

---

| | | |
|:---|:---|:---|
| **Reconciliation of Free Cash Flow** | *Six Months Ended* | *Six Months Ended* |
|  | *Jun 30, 2025* | *Jun 30, 2024* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* |
| Cash provided by (used for) operating activities - continuing operations (GAAP) | $(366) | $1292 |
| Capital expenditures | (1347) | (1437) |
| Free Cash Flow (non-GAAP) | $(1713) | $(145) |

---

---

| | | |
|:---|:---|:---|
| **Reconciliation of Cash Flow Conversion (Cash Flow from Operations to Operating EBITDA)** | *Six Months Ended* | *Six Months Ended* |
| **Reconciliation of Cash Flow Conversion (Cash Flow from Operations to Operating EBITDA)** | *Jun 30, 2025* | *Jun 30, 2024* |
| In millions | *Jun 30, 2025* | *Jun 30, 2024* |
| Net income (loss) (GAAP) | $(1091) | $996 |
| + Provision for income taxes | 58 | 61 |
| &nbsp;&nbsp;Income (loss) before income taxes | $(1033) | $1057 |
| - Interest income | 67 | 107 |
| + Interest expense and amortization of debt discount | 425 | 396 |
| - Significant items ¹ | (884) | (147) |
| Operating EBIT (non-GAAP) | $209 | $1493 |
| + Depreciation and amortization | 1438 | 1402 |
| Operating EBITDA (non-GAAP) | $1647 | $2895 |
| Cash provided by (used for) operating activities - continuing operations (GAAP) | $(366) | $1292 |
| Cash flow from operations to net income (GAAP) <sup>2</sup> | N/A | 129.7% |
| Cash Flow Conversion (Cash flow from operations to Operating EBITDA) (non-GAAP) | (22.2)% | 44.6% |

---

1. The six months ended June 30, 2025 includes: severance and related benefit costs and impairment charges related to the 2025 Restructuring Program; implementation costs associated with the Company's 2025 Restructuring Program and the sale of membership interests of the Company's wholly owned subsidiary, Diamond Infrastructure Solutions; a gain on the sale of the soil fumigation product line; a gain associated with the reassessment of liabilities for certain accrued Groundwater Matters, partially offset by the settlement of a separate claim related to Groundwater Matters; charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution; charges related to an arbitration agreement for historical product claims from a divested business; a loss on early extinguishment of debt; restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. The six months ended June 30, 2024 includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program and impairment charges related to write-downs of certain manufacturing assets. See Note 23 to the Consolidated Financial Statements for additional information.

2. Cash flow from operations to net income is not applicable for the six months ended June 30, 2025 due to a net loss for the period.

**Liquidity & Financial Flexibility**

The Company's primary source of incremental liquidity is cash flows from operating activities. The generation of cash from operations over the economic cycle and the Company's ability to access capital markets is expected to meet the Company's cash requirements for working capital, capital expenditures, debt maturities, contributions to pension plans, dividend distributions to stockholders, share repurchases and other needs. In addition to cash from operating activities, the Company's current liquidity sources also include TDCC's U.S. and Euromarket commercial paper programs, committed and uncommitted credit facilities, committed accounts receivable facilities, a medium-term notes program, a U.S. retail note program ("InterNotes®") and other debt markets.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

The Company continues to maintain a strong financial position with all of its committed credit facilities undrawn and fully available at June 30, 2025. Cash and committed and available forms of liquidity were $12.3 billion at June 30, 2025. The Company also has no substantive long-term debt maturities due until 2027. As a well-known seasoned issuer, the Company may issue debt at any time as an additional source of liquidity. Additional details on sources of liquidity are as follows:

*Commercial Paper*

TDCC issues promissory notes under its U.S. and Euromarket commercial paper programs. TDCC had no commercial paper outstanding at June 30, 2025. TDCC maintains access to the commercial paper market at competitive rates. Amounts outstanding under TDCC's commercial paper programs during the period may be greater or less than the amount reported at the end of the period. Subsequent to June 30, 2025, TDCC issued commercial paper and had approximately $2 billion of commercial paper outstanding at July 25, 2025.

*Committed Credit Facilities*

The Company also has the ability to access liquidity through TDCC's committed and available credit facilities. At June 30, 2025, TDCC had total committed and available credit facilities of $8.4 billion.

*Uncommitted Credit Facilities*

The Company has entered into various uncommitted bilateral credit arrangements as a potential source of excess liquidity. These lines can be used to support short-term liquidity needs and for general purposes. The Company had no drawdowns outstanding at June 30, 2025.

*Accounts Receivable Securitization Facilities*

In addition to the above credit facilities, the Company maintains a committed accounts receivable facility in the United States where eligible trade accounts receivable, up to $900 million, may be sold at any point in time. The Company also maintains a committed accounts receivable facility in Europe where eligible trade accounts receivable, up to €500 million, may be sold at any point in time. These facilities are set to expire in November 2025. In the first six months of 2025, there were $106 million in sales of receivables under the U.S. and Europe committed accounts receivable facilities ($264 million in sales of receivables in the first six months of 2024). At June 30, 2025, approximately $9 million of sold receivables were outstanding.

In addition, the Company has an uncommitted accounts receivable facility in the United States providing additional liquidity. This facility is set to expire in November 2025. Sales of receivables under this facility were $147 million in the first six months of 2025 ($378 million in sales of receivables in the first six months of 2024). At June 30, 2025, approximately $13 million of sold receivables were outstanding. See Note 12 to the Consolidated Financial Statements for additional information.

*Early Settlement of Letters of Credit*

The Company utilizes, from time-to-time, letters of credit discounting programs to manage and expedite the settlement of letters of credit in certain regions. These letters of credit are associated with accounts receivable and the Company retains no interest in the transferred letters of credit or receivables once sold.

*Accounts Receivable Discounting Facilities*

The Company has access to accounts receivable discounting facilities, under which receivables are transferred with limited recourse. The Company retains no interest in the transferred receivables once sold. Sales of receivables under this facility were $285 million in the first six months of 2025 ($408 million sales of receivables in the first six months of 2024). At June 30, 2025, approximately $12 million of sold receivables were outstanding. See Note 12 to the Consolidated Financial Statements for additional information.

The Company maintains these facilities and also participates in certain customers' supply chain financing and other early pay programs as a routine source of working capital.

*Company-Owned Life Insurance*

The Company has investments in company-owned life insurance ("COLI") policies, which are recorded at their cash surrender value as of each balance sheet date. The Company has the ability to monetize its investment in its COLI policies as an additional source of liquidity. At June 30, 2025, the Company had monetized $200 million of its existing COLI policies' surrender value (zero at December 31, 2024). See Note 6 to the Consolidated Financial Statements for additional information.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

*Shelf Registration - U.S.* 

On June 13, 2025, Dow Inc. and TDCC filed a shelf registration statement with the U.S. Securities and Exchange Commission. The shelf indicates that Dow Inc. may offer common stock; preferred stock; depositary shares; debt securities; guarantees; warrants to purchase common stock, preferred stock and debt securities; and stock purchase contracts and stock purchase units, with pricing and availability of any such offerings depending on market conditions. The shelf also indicates that TDCC may offer debt securities, guarantees and warrants to purchase debt securities, with pricing and availability of any such offerings depending on market conditions. In the third quarter of 2025, TDCC intends to file a prospectus supplement under this shelf registration to register an undetermined amount of securities for issuance under InterNotes®. Also, in the third quarter of 2025, TDCC intends to file a prospectus supplement under this shelf registration to register an undetermined amount of securities for issuance under a medium-term notes program.

*Debt*

As the Company continues to maintain its strong balance sheet and financial flexibility, management is focused on net debt (a non-GAAP financial measure), as the Company believes this is the best representation of its financial leverage at this point in time. As shown in the following table, net debt is equal to total gross debt minus "Cash and cash equivalents" and "Marketable securities."

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Total Debt** | *Dow Inc.* | *Dow Inc.* | *TDCC* | *TDCC* |
|  | *Jun 30, 2025* | *Dec 31, 2024* | *Jun 30, 2025* | *Dec 31, 2024* |
| In millions | *Jun 30, 2025* | *Dec 31, 2024* | *Jun 30, 2025* | *Dec 31, 2024* |
| Notes payable | $149 | $135 | $149 | $135 |
| Long-term debt due within one year | 401 | 497 | 401 | 497 |
| Long-term debt | 16247 | 15711 | 16247 | 15711 |
| &nbsp;&nbsp;&nbsp;Gross debt | $16797 | $16343 | $16797 | $16343 |
| &nbsp;&nbsp;&nbsp; - Cash and cash equivalents | 2399 | 2189 | 2399 | 2189 |
| &nbsp;&nbsp; - Marketable securities <sup>1</sup> | 307 | 383 | 307 | 383 |
| &nbsp;&nbsp;&nbsp;Net debt | $14091 | $13771 | $14091 | $13771 |
| Total equity | $18592 | $17851 | $18799 | $18032 |
| Gross debt as a percent of total capitalization | 47.5% | 47.8% | 47.2% | 47.5% |
| Net debt as a percent of total capitalization | 43.1% | 43.5% | 42.8% | 43.3% |

---

1. Included in "Other current assets" in the consolidated balance sheets.

The Company may at any time repurchase certain debt securities in the open market or in privately negotiated transactions subject to: the applicable terms under which any such debt securities were issued, certain internal approvals of the Company, and applicable laws and regulations of the relevant jurisdiction in which any such potential transactions might take place. This in no way obligates the Company to make any such repurchases nor should it be considered an offer to do so.

TDCC's public debt instruments and primary, private credit agreements contain, among other provisions, certain customary restrictive covenant and default provisions. TDCC's most significant debt covenant with regard to its financial position is the obligation to maintain the ratio of its consolidated indebtedness to consolidated capitalization at no greater than 0.70 to 1.00 at any time the aggregate outstanding amount of loans under the Five Year Competitive Advance and Revolving Credit Facility Agreement ("Revolving Credit Agreement") equals or exceeds $500 million. The ratio of TDCC's consolidated indebtedness to consolidated capitalization as defined in the Revolving Credit Agreement was 0.45 to 1.00 at June 30, 2025. Management believes TDCC was in compliance with all of its covenants and default provisions at June 30, 2025. For information on TDCC's debt covenants and default provisions, see Note 14 to the Consolidated Financial Statements included in the 2024 10-K. There were no material changes to the debt covenants and default provisions related to TDCC's outstanding long-term debt and primary, private credit agreements in the first six months of 2025.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

In the first quarter of 2025, the Company completed debt neutral liability management activities. The Company issued $1 billion of senior unsecured notes. The offering included $400 million aggregate principal amount of 5.35 percent notes due 2035 and $600 million aggregate principal amount of 5.95 percent notes due 2055. The Company used the proceeds to complete cash tender offers for certain debt securities. In total, $943 million aggregate principal amount was tendered and retired. As a result, the Company recognized a pretax loss of $60 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income, related to Corporate.

In the first six months of 2025, the Company issued an aggregate principal amount of $107 million of InterNotes<sup>®</sup>. Additionally, the Company repaid $125 million of long-term debt at maturity.

While taking into consideration the current economic environment, management expects that the Company will continue to have sufficient liquidity and financial flexibility to meet all of its business obligations.

**Credit Ratings**

At June 30, 2025, TDCC's credit ratings were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Credit Ratings** | *Long-Term Rating* | *Short-Term Rating* | *Outlook* |
| Fitch Ratings | BBB+ | F1 | Stable |
| Moody's Ratings | Baa2 | P-2 | Negative |
| Standard & Poor's | BBB | A-2 | Negative |

---

On February 21, 2025, Standard & Poor's affirmed TDCC's BBB and A-2 rating, and revised its outlook to negative from stable. Standard & Poor's decision was made as part of their annual review process and reflects the Company's supportive financial policies, scale, liquidity and cost-advantaged footprint. On July 7, 2025, Moody's Ratings announced a long-term credit rating change for TDCC from Baa1 to Baa2 and affirmed TDCC's P-2 rating and its outlook of negative. Moody's Ratings decision was made to reflect the impact of current market conditions on the Company's earnings, including the impact of global trade policy uncertainty and capacity additions in the industry, while recognizing the Company's strong asset base, strategic cost actions and long-term commitment to maintaining investment-grade quality.

**Dividends**

*Dow Inc.*

Dow Inc. has paid dividends on a quarterly basis since the separation from DowDuPont and expects to continue to do so, subject to approval by the Board. On July 24, 2025, the Company announced a 50 percent reduction to its dividend declared for the third quarter of 2025. The following table summarizes dividends declared and paid to common stockholders of record in 2025:

---

| | | | |
|:---|:---|:---|:---|
| **Dow Inc. Dividends Declared and Paid** | **Dow Inc. Dividends Declared and Paid** | **Dow Inc. Dividends Declared and Paid** | **Dow Inc. Dividends Declared and Paid** |
| *Declaration Date* | *Record Date* | *Payment Date* | *Amount (per share)* |
| February 13, 2025 | February 28, 2025 | March 14, 2025 | $0.70 |
| April 10, 2025 | May 30, 2025 | June 13, 2025 | $0.70 |
| July 24, 2025 | August 29, 2025 | September 12, 2025 | $0.35 |

---

*TDCC*

TDCC has committed to fund Dow Inc.'s dividends paid to common stockholders and share repurchases, as approved by the Board, as well as certain governance expenses. Funding is accomplished through intercompany loans. TDCC's Board reviews and determines a dividend distribution to Dow Inc. to settle the intercompany loans. For the three months ended June 30, 2025, TDCC declared and paid a dividend of $470 million to Dow Inc. ($985 million for the six months ended June 30, 2025). At June 30, 2025, TDCC's intercompany loan balance with Dow Inc. was insignificant.

**Share Repurchase Program**

On April 13, 2022, the Board approved a share repurchase program authorizing up to $3 billion for the repurchase of the Company's common stock, with no expiration date. The Company did not repurchase any of its common stock in the second quarter of 2025 (zero in the first six months of 2025). At June 30, 2025, approximately $931 million of the share repurchase program authorization remained available for repurchases. As previously

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

announced, the Company intends to repurchase shares at a minimum to cover dilution over the economic cycle. The Company may from time to time expand its share repurchases beyond dilution, based on a number of factors including macroeconomic conditions, free cash flow generation, and the Dow share price. Any share repurchases, when coupled with the Company's dividends, are intended to implement the long-term strategy of targeting shareholder remuneration of approximately 65 percent of Operating Net Income over the economic cycle.

**Pension Plans**

The Company has both funded and unfunded defined benefit pension plans that cover employees in the United States and a number of other countries. The Company's funding policy is to contribute to funded plans when pension laws and/or economics either require or encourage funding.

As part of its ongoing pension de-risking initiatives, the Company initiated the termination of certain U.S. tax-qualified pension plans which include the tax-qualified benefit obligations for substantially all employees hired after January 1, 2008, who earned benefits based on a set percentage of annual pay, plus interest. As part of the plan termination process, the Company will offer participants of these plans annuity or lump sum distribution options. Final asset distributions are expected to be paid from plan assets in the fourth quarter of 2025. The Company anticipates that these asset distributions will result in pension settlement charges, with the amounts dependent on various factors, including interest rates, plan asset returns, annuity pricing and participant distribution elections.

See Note 18 to the Consolidated Financial Statements and Note 19 to the Consolidated Financial Statements included in the 2024 10-K for additional information related to the Company's pension plans.

**Restructuring**

The 2025 Restructuring Program is expected to result in additional cash expenditures of $700 million primarily over the next four years and consist primarily of severance and related benefits costs, implementation costs related to decommissioning and demolition and additional costs associated with exit and disposal activities. Restructuring implementation costs totaled $5 million for the three and six months ended June 30, 2025.

Restructuring implementation and efficiency costs related to the 2023 Restructuring Program were zero and $50 million for the three and six months ended June 30, 2025, respectively ($56 million and $102 million for the three and six months ended June 30, 2024, respectively).

The Company expects to incur additional costs in the future related to its restructuring activities, which will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits related to its other optimization activities. These costs cannot be reasonably estimated at this time. See Note 5 to the Consolidated Financial Statements for additional information on the Company's restructuring activities.

**Contractual Obligations**

Information related to the Company's contractual obligations, commercial commitments and expected cash requirements for interest can be found in Notes 14, 15, 16 and 19 to the Consolidated Financial Statements included in the 2024 10-K. With the exception of the items noted below, there have been no material changes in the Company's contractual obligations since December 31, 2024.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Contractual Obligations at Jun 30, 2025** | *Payments Due In* | *Payments Due In* | *Payments Due In* | *Payments Due In* |  |
| In millions | *2025* | *2026-2027* | *2028-2029* | *2030 and beyond* | *Total* |
| *Dow Inc.* |  |  |  |  |  |
| &nbsp;&nbsp;Expected cash requirements for interest <sup>1</sup> | $417 | $1557 | $1474 | $9846 | $13294 |
| &nbsp;&nbsp;Purchase obligations <sup>2</sup> | 1509 | 4588 | 3485 | 15430 | 25012 |
| &nbsp;&nbsp;Total | $1926 | $6145 | $4959 | $25276 | $38306 |

---

1. Cash requirements for interest on long-term debt was calculated using current interest rates at June 30, 2025, and includes $130 million of various floating rate notes.

2. Includes outstanding purchase orders and other commitments greater than $1 million obtained through a survey conducted within the Company. The increase from December 31, 2024 was primarily due to supply agreements related to the Company's Fort Saskatchewan Path2Zero project and contract term extensions.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Fair Value Measurements**

See Note 21 to the Consolidated Financial Statements for information concerning fair value measurements.

**OTHER MATTERS**

**Critical Accounting Estimates**

The preparation of financial statements and related disclosures in accordance with accounting principles generally accepted in the United States of America requires management to make judgments, assumptions and estimates that affect the amounts reported in the consolidated financial statements and accompanying notes. Note 1 to the Consolidated Financial Statements included in the 2024 10-K describes the significant accounting policies and methods used in the preparation of the consolidated financial statements. The Company's critical accounting policies that are impacted by judgments, assumptions and estimates are described in Management's Discussion and Analysis of Financial Condition and Results of Operations included in the 2024 10-K. Since December 31, 2024, there have been no material changes in the Company's accounting policies that are impacted by judgments, assumptions and estimates.

*2025 Goodwill Impairment Testing*

In the second quarter of 2025, the Board approved actions to shut down certain upstream manufacturing assets. As a result of the announced actions, the Company identified potential indicators of goodwill impairment and evaluated whether the fair value of any reporting unit may be less than its carrying amount. The Company identified one reporting unit for which a quantitative interim goodwill impairment test was required. The results of the quantitative impairment test concluded that no goodwill impairment existed, as the fair value exceeded the carrying value of the reporting unit. Management will continue to monitor macroeconomic conditions and industry-specific developments that may impact the Company's financial performance and the recoverability of goodwill. For additional information, see Notes 5 and 11 to the Consolidated Financial Statements.

**Asbestos-Related Matters of Union Carbide Corporation**

Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past several decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide's premises, and Union Carbide's responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. ("Amchem"). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide's products.

The table below provides information regarding asbestos-related claims pending against Union Carbide and Amchem based on criteria developed by Union Carbide and its external consultants:

---

| | | |
|:---|:---|:---|
| **Asbestos-Related Claim Activity** | *2025* | *2024* |
| Claims unresolved at Jan 1 | 5813 | 6367 |
| Claims filed | 2195 | 2182 |
| Claims settled, dismissed or otherwise resolved | (1456) | (2370) |
| Claims unresolved at Jun 30 | 6552 | 6179 |
| Claimants with claims against both Union Carbide and Amchem | (1118) | (1016) |
| Individual claimants at Jun 30 | 5434 | 5163 |

---

Plaintiffs' lawyers often sue numerous defendants in individual lawsuits or on behalf of numerous claimants. As a result, the damages alleged are not expressly identified as to Union Carbide, Amchem or any other particular defendant, even when specific damages are alleged with respect to a specific disease or injury. For these reasons and based upon Union Carbide's litigation and settlement experience, Union Carbide does not consider the damages alleged against Union Carbide and Amchem to be a meaningful factor in its determination of any potential asbestos-related liability.

For additional information, see Asbestos-Related Matters of Union Carbide Corporation in Note 14 to the Consolidated Financial Statements; Part II, Item 1. Legal Proceedings; and Note 15 to the Consolidated Financial Statements included in the 2024 10-K.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

See Note 20 to the Consolidated Financial Statements and Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2024, for information on the Company's utilization of financial instruments and an analysis of the sensitivity of these instruments.

**ITEM 4. CONTROLS AND PROCEDURES**

**Evaluation of Disclosure Controls and Procedures**

As of the end of the period covered by this Quarterly Report on Form 10-Q, Dow Inc. and The Dow Chemical Company (the "Companies") carried out an evaluation, under the supervision and with the participation of the Companies' Disclosure Committee and the Companies' management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Companies' disclosure controls and procedures pursuant to paragraph (b) of Exchange Act Rules 13a-15 and 15d-15. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Companies' disclosure controls and procedures were effective.

**Changes in Internal Control Over Financial Reporting**

There were no changes in the Companies' internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that was conducted during the quarter ended June 30, 2025, that have materially affected, or are reasonably likely to materially affect, the Companies' internal control over financial reporting.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Dow Inc. and Subsidiaries**<br>**The Dow Chemical Company and Subsidiaries**<br>**PART II – OTHER INFORMATION**<br>

**ITEM 1. LEGAL PROCEEDINGS**

**Asbestos-Related Matters of Union Carbide Corporation**

No material developments regarding this matter occurred in the first six months of 2025. For a current status of this matter, see Note 14 to the Consolidated Financial Statements.

**Environmental Proceedings**

In October 2023, Region 6 of the U.S. Environmental Protection Agency ("EPA") conducted an inspection of the Company's Louisiana Operations under the EPA's Risk Management Program ("RMP"). The inspection was initiated due to an incident at the Company's Glycol-2 unit in Plaquemine, Louisiana, on July 14, 2023, as previously disclosed by the Company. The EPA published its inspection report on January 26, 2024. On January 3, 2025, the Company received a Notice Letter from the EPA's enforcement branch, which formally alleged 21 violations of RMP and Clean Air Act requirements and offered the Company an opportunity to confer with the EPA. Discussions between the Company and EPA are ongoing.

**ITEM 1A. RISK FACTORS**

Since December 31, 2024, there have been no material changes to the Company's Risk Factors, except as noted below, which was updated in the first and second quarters of 2025:

**Global Economic Considerations: The Company operates in a global, competitive environment which gives rise to operating and market risk exposure.**

The Company sells its broad range of products and services in a competitive, global environment, and competes worldwide for sales on the basis of product quality, price, technology and customer service. Increased levels of competition could result in lower prices or lower sales volume, which could have a negative impact on the Company's results of operations. Sales of the Company's products are also subject to extensive federal, state, local and foreign laws and regulations; trade agreements; import and export controls; taxes; and duties and tariffs. The imposition of additional regulations, controls, taxes, duties and tariffs or changes to bilateral and regional trade agreements could result in lower sales volume, which could negatively impact the Company's results of operations.

In early 2025, the United States made significant changes to its long-standing trade policies and announced significant new tariffs on virtually all imported goods, with the exception of certain goods that are compliant with the United States-Mexico-Canada Agreement, a trade agreement which became effective in 2020. The United States subsequently announced a reduction of the new tariffs, with certain exceptions, as it negotiates trade agreements. However, the resulting average U.S. tariff rate rose to the highest level since the 1930s. In July 2025, the United States announced it will impose higher tariff rates, effective August 1, 2025, on imports from certain specified trading partners where trade negotiations have not satisfactorily progressed. In response to these actions, certain U.S. trading partners imposed or are publicly considering retaliatory tariffs on U.S. imports. Shifts in tariffs, import/export restrictions, trade sanctions, sector specific trade barriers, and other governmental trade actions, whether enacted by the United States or other countries, and the associated uncertainty of long-term trade policies, could impact the Company's sales volume, sales price, and production and other costs. Changes in trade policies may also cause disruptions to material sourcing and availability, global supply chains and logistics and access to end markets. Additionally, changes in U.S. trade policy may create shifts in global market dynamics, disrupt the long-term planning process for governments and private enterprises and result in continued global financial market volatility. The impact of these changes in trade policies and the resulting trade and market uncertainty could have a negative impact on the Company's results of operations.

Economic conditions around the world, and in certain industries and geographic regions in which the Company does business, also impact sales price and volume and the efficacy of the Company's supply chain. For example, long-term market uncertainty, an economic downturn driven by trade policies and inflationary pressures, and higher input costs have reduced demand for the Company's products, resulting in decreased sales price and volume in recent years which have yet to recover. Adverse economic conditions have also caused supply chain constraints. These factors have had a negative impact on the Company's results of operations. Additionally, political tensions; war, including the ongoing conflicts in the Middle East and between Russia and Ukraine with the related sanctions and

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

export restrictions; terrorism; epidemics; pandemics; or political instability in the geographic regions or industries in which the Company sells its products could further reduce demand for the Company's products and result in decreased sales price and volume or supply chain disruptions, which could have a negative impact on the Company's results of operations.

The United States, Canada, the European Union and other countries imposed economic sanctions on Russia in response to its February 2022 invasion of Ukraine. As a result, Dow suspended purchases of feedstocks and energy from Russia and stopped all investments in Russia. Additionally, Dow reduced its product offerings and is currently supplying Russia with only limited non-sanctioned goods. These actions have not had and are not expected to have a material impact on the Company's financial condition or results of operations. However, the fluidity and continuation of the conflict may result in additional economic sanctions and other impacts which could have a negative impact on the Company's financial condition, results of operations and cash flows. These include decreased sales; supply chain and logistics disruptions; volatility in foreign exchange rates and interest rates; inflationary pressures on and availability of raw materials and energy, most notably in Europe; and heightened cybersecurity threats. Further, the intensity and duration of conflicts in the Middle East and potential expansion of hostilities in the region are difficult to predict and could disrupt the Company's supply chain operations, which could have a negative impact on the Company's results of operations.

In addition, volatility and disruption of financial markets could limit the ability of Dow's customers and suppliers to obtain adequate financing to maintain operations, which could result in a decrease in sales volume and have a negative impact on the Company's results of operations. The Company's global business operations also give rise to market risk exposure related to changes in inflation, foreign currency exchange rates, including the impact of foreign currency exchange rates resulting from highly inflationary economies such as Argentina, interest rates, commodity prices and other market factors such as equity prices. To manage such risks, the Company enters into hedging and other investment transactions, where deemed appropriate, pursuant to established guidelines and policies. If the Company fails to effectively manage such risks, it could have a negative impact on its results of operations.

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

**Issuer Purchases of Equity Securities**

The following table provides information regarding purchases of Dow Inc. common stock by the Company during the three months ended June 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Issuer Purchases of Equity Securities** | **Issuer Purchases of Equity Securities** | **Issuer Purchases of Equity Securities** | *Total number of shares purchased as part of the Company's publicly announced share repurchase program* | *Approximate dollar value of shares that may yet be purchased under the Company's publicly announced share repurchase program* <sup>1</sup><br>*(In millions)* |
| *Period* | *Total number of shares purchased* | *Average price paid per share* | *Total number of shares purchased as part of the Company's publicly announced share repurchase program* | *Approximate dollar value of shares that may yet be purchased under the Company's publicly announced share repurchase program* <sup>1</sup><br>*(In millions)* |
| April 2025 |  | $— |  | $931 |
| May 2025 |  | $— |  | $931 |
| June 2025 |  | $— |  | $931 |
| Second quarter 2025 |  | $— |  | $931 |

---

1. On April 13, 2022, the Dow Inc. Board approved a share repurchase program authorizing up to $3.0 billion for the repurchase of the Company's common stock, with no expiration date.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**ITEM 5. OTHER INFORMATION**

During the second quarter of 2025, the Company's directors and officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) did not adopt, terminate or modify Rule 10b5-1 or non-rule 10b5-1 trading arrangements (as defined in Item 408 of Regulation S-K).

**ITEM 6. EXHIBITS**

---

| | |
|:---|:---|
| **EXHIBIT NO.** | **DESCRIPTION** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3 | Dow Inc. agrees to provide the SEC, on request, copies of all other such indentures and instruments that define the rights of holders of long-term debt of Dow Inc. and its consolidated subsidiaries, including The Dow Chemical Company, pursuant to Item 601(b)(4)(iii)(A) of Regulation S-K. |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[23](dowinc-q26302025ex23.htm)</u> \* | Ankura Consulting Group, LLC's Consent. |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[31.1](dowinc-q26302025ex311.htm)</u> \* | Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[31.2](dowinc-q26302025ex312.htm)</u> \* | Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[32.1](dowinc-q26302025ex321.htm)</u> \* | Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[32.2](dowinc-q26302025ex322.htm)</u> \* | Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| &nbsp;&nbsp;&nbsp;101.INS | The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| &nbsp;&nbsp;&nbsp;101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| &nbsp;&nbsp;&nbsp;101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| &nbsp;&nbsp;&nbsp;101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| &nbsp;&nbsp;&nbsp;101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| &nbsp;&nbsp;&nbsp;101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| &nbsp;&nbsp;&nbsp;104 | Cover Page Interactive Data File. The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |

---

\* Filed herewith

**TRADEMARK LISTING**

The following registered trademark of InspereX Holdings LLC appears in this report: InterNotes®®™ Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow, except as otherwise specified.

------

*<u>[**Table of Contents**](#i139c2cbd4ae6490591e4e20286513220_10)</u>*

**Dow Inc. and Subsidiaries**<br>**The Dow Chemical Company and Subsidiaries**<br>**Signature**<br>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DOW INC.

THE DOW CHEMICAL COMPANY

Date: July 25, 2025

---

| |
|:---|
| /s/ ANDREA L. DOMINOWSKI |
| Andrea L. Dominowski<br>Controller and Vice President of Controllers<br>(Authorized Signatory and <br>Principal Accounting Officer) |

---

## Ex-23

---

| | |
|:---|:---|
| **Ankura Consulting Group, LLC's Consent** | **EXHIBIT 23** |

---

Ankura Consulting Group, LLC ("Ankura") hereby consents to the use of Ankura's name and the reference to Ankura's reports in this Quarterly Report on Form 10-Q of Dow Inc. and The Dow Chemical Company for the period ended June 30, 2025, and the incorporation by reference thereof in the following Registration Statements of Dow Inc. and The Dow Chemical Company:

**<u>DOW INC.</u>**

---

| | |
|:---|:---|
| Form S-3: | |
| Nos. | 333-230668 |
| | 333-265556 |
| | 333-288028 |
| Form S-8: | |
| Nos. | 333-220352-01 |
| | 333-230680 |
| | 333-230681 |
| | 333-255472 |
| | 333-255473 |

---

**<u>THE DOW CHEMICAL COMPANY</u>**

---

| | |
|:---|:---|
| Form S-3: | |
| No. | 333-265556-01 |
| | 333-288028-01 |
| Form S-4: | |
| No. | 333-234108 |
| Form S-8: | |
| Nos. | 33-61795 |
| | 333-40271 |
| | 333-91027 |
| | 333-103519 |
| | 333-220352 |

---

Date: July 25, 2025

---

| |
|:---|
| /s/ AMY BROCKMAN |
| Amy Brockman<br>Senior Managing Director<br>Ankura Consulting Group, LLC |

---

## Exhibit 31.1

---

| | |
|:---|:---|
| **Dow Inc. and Subsidiaries<br>The Dow Chemical Company and Subsidiaries** | **EXHIBIT 31.1** |

---

**Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**

I, Jim Fitterling, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Dow Inc. and The Dow Chemical Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrants as of, and for, the periods presented in this report;

4. The registrants' other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrants and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrants, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrants' disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrants' internal control over financial reporting that occurred during the registrants' most recent fiscal quarter (the registrants' fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants' internal control over financial reporting; and

5. The registrants' other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants' auditors and the audit committee of registrants' board of directors (or persons performing the equivalent function):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants' ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants' internal control over financial reporting.

Date: July 25, 2025

---

| |
|:---|
| /s/ JIM FITTERLING |
| Jim Fitterling<br>Chair and Chief Executive Officer |

---

## Exhibit 31.2

---

| | |
|:---|:---|
| **Dow Inc. and Subsidiaries<br>The Dow Chemical Company and Subsidiaries** | **EXHIBIT 31.2** |

---

**Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**

I, Jeffrey L. Tate, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Dow Inc. and The Dow Chemical Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrants as of, and for, the periods presented in this report;

4. The registrants' other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrants and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrants, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrants' disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrants' internal control over financial reporting that occurred during the registrants' most recent fiscal quarter (the registrants' fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants' internal control over financial reporting; and

5. The registrants' other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants' auditors and the audit committee of registrants' board of directors (or persons performing the equivalent function):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants' ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants' internal control over financial reporting.

Date: July 25, 2025

---

| |
|:---|
| /s/ JEFFREY L. TATE |
| Jeffrey L. Tate<br>Chief Financial Officer |

---

## Exhibit 32.1

---

| | |
|:---|:---|
| **Dow Inc. and Subsidiaries<br>The Dow Chemical Company and Subsidiaries** | **EXHIBIT 32.1** |

---

**Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

I, Jim Fitterling, Chair and Chief Executive Officer of Dow Inc. and The Dow Chemical Company (the "Companies"), certify that:

1. The Quarterly Report on Form 10-Q of the Companies for the quarter ended June 30, 2025 as filed with the Securities and Exchange Commission (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Companies.

Date: July 25, 2025

---

| |
|:---|
| /s/ JIM FITTERLING |
| Jim Fitterling<br>Chair and Chief Executive Officer |

---

## Exhibit 32.2

---

| | |
|:---|:---|
| **Dow Inc. and Subsidiaries<br>The Dow Chemical Company and Subsidiaries** | **EXHIBIT 32.2** |

---

**Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

I, Jeffrey L. Tate, Chief Financial Officer of Dow Inc. and The Dow Chemical Company (the "Companies"), certify that:

1. The Quarterly Report on Form 10-Q of the Companies for the quarter ended June 30, 2025 as filed with the Securities and Exchange Commission (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Companies.

Date: July 25, 2025

---

| |
|:---|
| /s/ JEFFREY L. TATE |
| Jeffrey L. Tate<br>Chief Financial Officer |

---

<br>